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FAT PARTITIONING AND SUBCLINICAL CARDIOVASCULAR DISEASE 
AMONG WOMEN IN MENOPAUSAL TRANSITION 
 
Sanjaya Dhakal, PhD 
University of Pittsburgh, 2008 
 
 
Obesity is one of the major risk factors of atherosclerosis and arterial stiffness. 
Recent evidence suggests detrimental effect of fat mass rather than overall body mass. 
Abdominal fat has been indicated to have more negative impact than other fat depots. We 
evaluated the impact of regional fat distribution on atherosclerosis and compared the 
variances explained by 11-different adiposity measures on atherosclerosis and arterial 
stiffness among bi-racial women in menopausal transition. All analyses were cross-
sectional. 
In the first analysis, adjusted for age, race, menopausal status, insulin, systolic 
blood pressure (SBP), triglycerides, height, high-density lipoprotein (HDL) and smoking; 
proportions of total (p= 0.03) and trunk fats (p= 0.03) were positively associated with 
common carotid adventitial diameter (AD). In contrast, proportion of leg fat was 
negatively associated with AD (p= 0.03). SBP attenuated the significant associations of 
total and regional fat distribution with carotid IMT. 
In the second analysis, adjusted for age, race, menopausal status, height, SBP, 
low-density lipoprotein (LDL), HDL and insulin; waist circumference (WC) explained 
25.2% of variance in IMT and 27.0% of variance in AD, while proportion of trunk fat 
 v
 
 
explained 22.7% of variance in IMT and 25.1% of variance in AD, and area of visceral 
adipose tissue (VAT) explained 22.7% of variance in IMT and 25.8% of variance in AD. 
When adjusted for age, race, menopausal status, height, SBP, insulin and C-
reactive protein; WC, proportion of trunk fat and VAT explained comparable proportions 
of the variance in carotid-femoral pulse wave velocity (cfPWV) (WC, 9.0% of variance; 
proportion of trunk fat, 9.9%; and VAT, 10.3%). After adjusting for above mentioned 
variables, only proportion of total fat remained positively associated with cfPWV (p= 
0.04). 
Overall, our findings provide evidence for differential role of regional fat 
distribution on atherosclerosis but not on arterial stiffness. Moreover, WC seems to be as 
good as computed tomography (CT) and dual-energy x-ray absorptiometry (DXA) 
measures of fat in explaining variability on atherosclerosis and arterial stiffness. Given 
the cost, difficulty in maintenance and exposure to radiation associated with CT and 
DXA, the use of WC in future research may have great public health significance.   
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1.0     Dissertation Overview and Objective 
 
Increasing prevalence of obesity has been constantly reported from different parts of 
world and has been considered an epidemic by the World Health Organization (WHO). At 
present, more than one billion people are overweight and 300 million of them are clinically obese 
1. In 2003-2004, 32.2% of adult Americans were obese 2. Prevalence of obesity varies 
substantially by race, gender, age, geography etc.  
Recent findings suggest that fat deposition in different parts of the human body may act 
differentially inducing adverse health outcomes. A negative role of visceral fat on the onset of 
chronic diseases has been highlighted by several reports 3-5. Interestingly, some reports suggest 
that fat in lower extremities may be beneficial 6-8. Thus, precise measurement of fat distribution 
in human body may be important in clinical evaluation of morbid obesity so that appropriate 
intervention can be implemented to curb negative impacts of obesity. Commonly used 
anthropometric measures may not be precise enough to determine the true picture of morbid 
obesity in real life. With technological development, several new methods including, bio-
impedance (BIA), magnetic resonance imaging (MRI), dual-energy X-ray absorptiometry 
(DEXA) and computed tomography (CT) have emerged that are able to distinguish fat from lean 
and bone tissues and to estimate region-specific fat distribution.   
Available evidence indicates that obesity is directly and/or indirectly associated with 
increasing risks of chronic disease including diabetes, insulin resistance, coronary heart disease, 
stroke, physical disability, dyslipidemia, hypertension, osteoarthritis, gallbladder disease, sleep 
apnea, respiratory problems and some cancers 9. Currently, at least 34.2% of Americans have one 
or more risk factors of CVD 10. Evidence indicates that prevalence of CVD is higher among 
males than females until they reach in early-50s however, it is just the reverse there after. One 
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plausible reason for higher prevalence of CVD among women after the age 50 is vital changes in 
hormonal flow in their body as a result of menopause which occurs around mid-forties. Prior 
studies have found significant increase in abdominal obesity and CVD prevalence among post-
menopausal compared to pre-menopausal women 11. However, data on obesity and CVD during 
menopausal transition is still scare.  
This dissertation is planned to investigate changes in abdominal fat deposition and their 
impact on subclinical markers of CVD. This dissertation will attempt to address following 
research hypotheses; 
I. Higher abdominal fat is associated with increase in carotid intima-media thickness 
(IMT) and carotid adventitial diameter (AD), 
II. The variances on carotid IMT and AD by abdominal adiposity measured by waist 
circumference (anthropometry), trunk fat (DXA) and visceral adipose tissue (CT) are 
comparable and, 
III. Visceral adipose tissue (measured by CT) explains more variance on arterial stiffness 
(measured by pulse-wave velocity) than waist circumference or trunk fat (measured by 
DXA). 
  3
 
2.0 Background 
 
2.1 Obesity 
2.1.1  Epidemiology of Obesity 
 
Ever increasing obesity across the world has been recognized as one of the most 
important public health concerns today. While the number of deaths from under-nourishment is 
declining, the number of deaths attributed to obesity is at an all time high and is still increasing. 
Worldwide, more than one billion adults are overweight and at least 300 millions are clinically 
obese. In 2003, the highest proportions of obese people were in urban Samoa (75%) and the 
lowest (approx. 5%) in China, Japan and some African nations 1.  
Today, two in three Americans are either overweight or obese. In 2003-2004, 32.2% US 
adults (20 years of age or older) were obese (defined by body mass index (BMI)≥ 30 kilogram of 
weight/meter squared of height). Evidence suggests that prevalence of obesity varies widely 
across geographical regions, ethnic background, co-morbid conditions, gender and age 12. 
Obesity in the US was found to be more common among non-Hispanic African Americans 
(45.0%) followed by Mexican- Americans (36.8%) and non-Hispanic Caucasians (30.6%) 2. Fat 
accumulation among men and women varies considerably with natural aging (see figure 2-1). 
The highest prevalence of overweight and obesity in male starts early, after 35 years of age and 
then decreases slightly after the age of 75, whereas in female, the prevalence spikes after the age 
of 45 and decreases after the age of 65 11. These findings are partly explained by the change in 
hormonal flow at menopause are responsible for such variations, at least partly.  
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Figure 2-1 Prevalence of overweight and obesity in US by age and sex (1999 – 
2002) 
 
   
Recently, obesity has been increasing more rapidly than overweight. Proportion of 
overweight American, aged 20-74 years, has increased by more than 45% in 1999-2002 
compared to 1960-1962; whereas, for the same period and age group, obesity rate 
increased by more than 133% (figure 2-2) 11.  
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Figure 2-2 Overweight and obesity among American adults (1960-2002) 
 
 
Obesity is a complex chronic condition that results from interaction of environmental, 
social, behavioral and genetic factors. It has been believed that genes make people susceptible to 
obesity 13,14, which upon interaction with other environmental, social and behavioral factors for a 
long time ultimately leads to overweight and finally obesity. However, the exact magnitude of 
genetic contribution in prevalence of obesity is yet to be identified.  
From financial perspective, obesity induced negative health outcomes result in enormous 
amount of health care expenditures. According to Colditz et. al., direct cost of obesity (not 
overweight) in 1995 was 70 billions US dollars in the US, 7% of the US health care expenditures 
for the year 15. The estimate included the diagnosis and treatment costs (hospital or nursing home 
stay, medications, physician visits) incurred because of type II diabetes, coronary heart disease, 
hypertension, gall bladder disease, osteoarthritis and, breast endometrium and colon cancers. The 
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cost of obesity and overweight in 1998 was estimated to be 78.5 billion; 9.1% of the total annual 
US medical expenditures 16.  
2.1.2 Adipose Tissue Metabolism 
 
Adipose tissue represents 15-18% of the body weight in males and about 25% in females 
under normal physiologic conditions 17. Energy intake in excess to expenditure results in positive 
energy balance in the human body. Excess energy is stored, in the form of fat. Continuous 
increase in fat storage leads to obesity. It has been understood that adipocytes (fat cells) play a 
major metabolic role on food intake, energy balance, and metabolic homeostasis through 
endocrine hormones. The body receives fat either from dietary source (as lipid) or synthesizes 
from other nutrients including proteins and carbohydrates. Lipids in diet are available in the form 
of triglycerides, free fatty acids, cholesterols and other sterols. Also, excess proteins and 
carbohydrates in the body are metabolized by liver into lipids. Liver is primarily responsible for 
lipogenesis, whereas adipose tissue stores the lipid. Fat, first absorbed in small intestine are 
converted to triglyceride forming large fat globules with free fatty acids, phospholipids and 
sterols. These fat globules react with bile salts in intestinal lumen which are then hydrolyzed by 
pancreatic lipase and form monoglycerols and long chain free fatty acids. Monoacyglycerols are 
then converted to di- or tri- aciglycerols and cholesterol esters are formed from fatty acids.  
Chylomicrons are covered by a shell of protein, cholesterol and lipoprotein allowing 
lipids inside to float freely in the water-based bloodstream. The main purpose of chylomicrons is 
to emulsify dietary fats before they enter bloodstream. Chylomicrons then travel to thoracic duct 
that opens into a large vein called subclavin vein via lymphatic system. After breaking down of 
triglycerides by lipoprotein lipase into free fatty acids and glycerols, majority of glycerols travel 
to cells in liver and kidney through blood and turned into glucose. Adipose, muscle and other 
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cells in the neighborhood area absorb most free fatty acids for immediate fuel or are re-esterified 
into triglycerides. Adipose cells tend to re-esterify and store fatty acids as triglycerides, whereas, 
muscle cells tend to de-esterify and metabolize them. After uptake of triglycerides from 
chylomicrons, the remnants that mostly contain cholesterol and protein are then taken up by liver 
for further metabolism. Unabsorbed free fatty acids bind to albumin for distribution in the 
circulation.     
2.1.3 Assessment of Adiposity 
 
There are several ways to quantify obesity including anthropometric measurements 
(BMI, waist circumference (WC), waist-to-hip ratio (WHR), triceps skin folds etc), DXA, BIA, 
MRI, CT etc 18,19. Although not very precise, anthropometric measures are widely used in field 
research as markers of body fat because of their ease of use and cost-effectiveness. A historical 
overview of anthropometric indicators of abdominal obesity is given in table 2-1.  
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Table 2-1: Overview of adiposity measures 
 
Indicator Proposed by Initial Reason to use Merits Demerits 
Waist-Thigh Ratio 
(WTR) 
Ashwell et al 
(1978, 1982) 
To classify android vs 
gynoid obesity 
Better correlate of 
visceral fat/ risk 
factors than WHR 
- Reflects muscle & 
fat distribution, 
- not easy to interpret 
Waist-Hip Ratio 
(WHR) 
Krotkiewski 
et al (1983) 
Hartz et al 
(1983) 
To classify android vs 
gynoid obesity 
Good predictor of 
mortality & 
morbidity 
- Reflects muscle & 
fat distribution, 
- not easy to interpret 
Sagittal 
Abdominal 
Diameter (SAD) 
Kvist et al 
(1987) 
High correlation with 
visceral fat observed 
by CT scan 
Best correlate of 
visceral fat 
- Difficult to measure 
in field research than 
WC 
Waist-Height 
Ratio  
Higgings et 
al (1987) 
Lack of 
measurements of hip 
and thigh 
Better predictor of 
visceral fat than WC 
or WHR 
- Height inversely 
associated with 
morbidity/ mortality 
independent of fat 
distribution 
Conicity Index Valdez 
(1991) 
To standardize WC 
for body shape 
- Built-in adjustment 
of WC for height & 
weight 
- Does not require hip 
circumference 
- not easy to interpret 
Abdominal 
diameter-Mid 
thigh girth Ratio  
Kahn et al 
(1993) 
Better predictor of 
IHD & mortality from 
sudden coronary 
death than WHR 
Best simple index to 
predict morbidity and 
mortality 
-Reflect both muscle 
and fat distribution  
- not easy to interpret 
Waist 
Circumference 
 
Pouliot et al 
(1994) 
Lean et al 
(1995) 
-Correlation with 
visceral fat 
- Replacement of 
BMI and WHR 
- easy to interpret 
- Better correlate of 
visceral fat than 
WHR and WTR 
High correlation with 
BMI 
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BMI has been widely accepted as a marker of body weight relative to height in research 
and clinical practice. Table 2-2 describes the most commonly used cut-off levels of BMI to 
define under weight, healthy weight, over weight, and obesity in population. Anthropometric 
measures provide different information regarding the regional distribution of adiposity. WHR 
indicates upper versus lower adiposity, whereas WC more specifically reflects abdominal fat 
storage. Biological interpretation of WHR is not as straight as of WC, since the hip component 
incorporates fat and muscle mass at the gluteal level 20.  
 
 
Table 2-2. Classification of overweight/ obesity by BMI and associated disease risk 
 
BMI(kg/m2) Weight Class Obesity Class Disease Risk1 
<18.5 Underweight  - 
18.5-24.9 Normal Weight  - 
25.0-29.9 Overweight  Increased  
30.0-34.9 Obese I High 
35.0-39.9  II Very High 
>40.0 Extremely Obese III Extremely High 
 
1- Disease risk for type 2 diabetes, hypertension and CVD 
 
Although BMI is correlated with total fat mass and fat percent, it is not considered a 
precise indicator of underlying proportion of fat and lean tissues. Previous studies from Asia 
have reported that Asians have high visceral adipose tissue despite their normal range of BMI 21-
23. Similarly, Kunesova et al found WC and SAD as better predictors of metabolic variables and 
arterial blood pressure than WHR 24. More accumulation of fat in the visceral region than other 
parts of the body may partly explain these associations. In another study, BMI identified obesity 
in only 50.6% of racially mixed population and there were 49.4% false-negative results 
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(inaccurately classified as lean) 25 indicating the need to redefine obesity on the basis of visceral 
and/ or total fat content rather than just BMI.  
 
2.1.3.1 Dual Energy X-ray Absorptiometry and Computed Tomography 
   
Although anthropometric measures are most commonly used markers of adiposity in 
clinical as well as research settings, they have limited ability to differentiate the contribution of 
fat and lean mass on disease outcomes. Hence, newer technologies DXA and CT that are able to 
differentiate fat and lean mass have been suggested as more precise and accurate in measuring 
the total and regional distribution of fat and lean mass and to estimate their contribution to 
disease outcomes 18,26. There is a substantial need for an ‘ideal’ marker of overall and regional 
adiposity that; a.) is accurate in measuring adiposity, b.) can predict disease risk in general 
population, c.) is applicable and acceptable in large population studies as well as in clinical 
settings and d.) is precise resulting in small measurement error. However, a clear agreement on 
ideal marker of overall adiposity and regional adiposity is still far from reach.  
DXA methodology is simple, suitable for general population including elderly and very 
sick people. Because of its ability to differentiate adipose tissue from lean and bone mass with 
low radiation and its better applicability in large population settings than CT and MRI, it is now 
considered the gold standard for body composition 18,26. The basic concept of DXA technology is 
the energy attenuation in vivo is a function of tissue composition. This technique assumes that 
the body is composed of three components; fat, bone and lean tissue, which are distinguishable 
by respective energy attenuation properties reflecting their differences in densities and chemical 
compositions. The human body is divided into a series of pixels within which the energy 
attenuation is measured at two energy levels. Within each pixel, proportions of only two 
components can be solved by the differential absorption of two energies. With increasing energy 
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levels, the difference in the attenuation properties for tissue decreases. Image generated by the 
scan is first analyzed to calculate the bone threshold and identify bone and non-bone points. 
Attenuation of x-ray by pure fat and non-bone lean tissue is known and the analysis proceeds on 
a point by point basis. Each point is sub-divided into fractions of lean and fat mass.  
CT is a noninvasive technique that uses X-rays in a fan-shaped beam detected by an array 
of detectors, available at the opposite side of a subject. CT, in addition to its ability to distinguish 
fat, lean and bone tissues has ability to identify visceral organs and to distinguish intra-
abdominal fat from subcutaneous fat 18,27. Like DXA, the basic concept of CT methodology 
relies on energy attenuation properties of different tissues. The intensity of the transmitted X-ray 
is detected by detectors providing information on bodily structures that the beam passed through 
28. Associated computer processes the cumulative information using available algorithm and 
produces cross-sectional image of the scanned area. These images can be used to distinguish 
visceral adipose tissues from subcutaneous adipose tissues. Radiation dose and associated cost 
have been its major disadvantage.  
 
2.1.4 Regional Distribution of Adipose Tissue  
 
Recent studies have highlighted that the differential impact of regional fat distribution 
may be more important than total fat on adverse health outcomes. Central adiposity, mainly 
assessed by anthropometric measurements including BMI, WC, WHR, is associated with 
cardiovascular morbidity and mortality 4,8,29-35. Further more, android fat accumulation in women 
is associated with cardiovascular morbidity and mortality, independent of the degree of obesity 
36. A major limitation of anthropometric measurements is its’ inability to distinguish fat from 
lean and bone tissues and differentiate fat stored in visceral organs from fat stored 
subcutaneously. Accumulation of VAT exerts more negative impacts on health outcomes than 
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subcutaneous fat 37-39. VAT is thought to be the main adiposity marker associated with traditional 
CVD risk factors because of it’s active pro-lipolytic activity and higher ability to deliver free 
fatty acids and inflammatory cytokines directly to systemic circulation than other fat depots26. 
Most importantly, free fatty acids released from VAT have direct access to liver which may 
impact negatively on hepatic insulin activity increasing the risk of diseases 9. Prior studies have 
also shown an inverse relationship of circulating adiponectin with abdominal adiposity 
suggesting lowered anti-atherogenic activity of adiponectin 40-43 with increased abdominal 
adiposity. 
It has been shown that visceral fat deposition varies by ethnicity, geography, culture, 
heredity, socio-economic factors, menopausal status etc 44. The prominent role of visceral 
adipose tissue on health outcomes including, metabolic syndrome, insulin resistance, CVD have 
been consistently shown in recent studies 45-48. On the other hand, some studies have identified a 
negative correlation between fat in lower extremities and glucose and lipid levels in 
postmenopausal women and elderly population 6,7. Lower levels of atherogenicity with increased 
peripheral fat mass and leg fat percentage has also been reported 8,49,50. This may be because the 
adipocytes in the lower extremities, particularly in the femoral-gluteal area are relatively 
sensitive to anti-lipolytic activity while being less sensitive to pro-lipolytic activity.  
Studies examining the impact of menopause on fat distribution have found inconsistent 
results. Different techniques employed to measure body fat have been suggested as one potential 
explanation for such discrepancies 51. A significant effect of menopause transition, independent 
of age and total adiposity, on body fat distribution has been reported consistently by prior studies 
that used DXA to determine abdominal adiposity 52 53-55. Studies using computed tomography 
have also found significant effect of menopause transition on body fat distribution even after 
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controlling for BMI or age 56,57. Kotani et al observed an accelerated accumulation of visceral 
adipose tissue (VAT) with increasing age among postmenopausal women. In another study, after 
adjusting for age and total fat mass, postmenopausal women had significantly more intra-
abdominal adipose tissue compared to pre-menopausal women58. Gambacciani et al., found 
increased abdominal fat accumulation, even during the perimenopausal period 59. Studies using 
WHR or waist circumference to define abdominal obesity failed to find significant effect of 
menopause on body fat distribution after adjusting for potential confounders including degree of 
obesity, BMI and age 56,60-68. 
 
2.2 Cardiovascular Disease 
 
2.2.1 Epidemiology of Cardiovascular Disease 
 
According to American Heart Association, over 71 million American adults were living 
with at least one type of CVD in 2003, while 37.3% of all deaths in the US were attributed to 
CVD in the same year 10. Out of 910,614 CVD deaths in the US in 2003, 53.1% were females. 
Although proportion of people dying of cardiovascular disease has been decreasing in recent 
years compared to 1950, it is still the number one killer in the US. According to Center for 
Disease Control and Prevention (CDC), probability at birth of eventually dying from major CVD 
is 47% 69. In general, CVD incidence and prevalence increases with age in both genders, the rate 
of increment is much higher among females after menopause (figure2-3). CVD also induces 
huge economic burden to the population. For 2006, CVD was expected to cost more than US $ 
400 billions in direct and indirect cost 10.  
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Figure 2-3: Prevalence of cardiovascular disease in USA by age and sex (1999 – 2002) 
 
 
2.2.2 Subclinical Cardiovascular Disease 
Atherosclerosis is the narrowing and hardening of arteries caused by the accumulation of 
cellular waste products, fatty substances, cholesterol and other substances within the intima-
media layer of the artery 70. Atherosclerosis is a slow, progressive disease that may start in 
childhood, although it does not become clinically apparent until young adulthood or later.  
In atherosclerotic process, endothelial layer (an interface between blood and artery, figure 
2-4) as weakens activates cell adhesion molecules that allow the attachment of leukocytes to 
endothelial wall 70,71. Monocyte chemoattractant protein-1 (MCP-1) activates leukocytes to enter 
the intima and they begin to store lipids. Next, leukocytes transforms into a lipid loaded 
macrophages called foam cell 70 which is considered the first major lesion of the atherosclerotic 
process and is commonly called ‘fatty streak’. By multiplication of smooth muscles cell that 
accumulate plaque, the lesion starts to grow forming a fibrous cap which causes to narrow lumen 
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diameter ultimately limiting blood flow. Fibrous cap if ruptured, with the continuous influx of 
macrophages and inflammatory cells into the plaque may lead to thrombosis and occlusion of 
arteries leading to CVD events including myocardial infarction and stroke 72-74.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2-4. Schematic illustration of various layers of the arterial wall 
(Source: http://bme.engr.ccny.cuny.edu/faculty/jtarbell/SMC%20images.htm)  
Several methods of measuring subclinical atherosclerosis have been suggested in 
literature including intima-media thickness, adventitial diameter, ankle-brachial index and 
calcification 73,75-77. Intima-media thickness and adventitial diameter of carotid artery were used 
as markers of subclinical atherosclerosis for the purpose of this dissertation. 
 
2.2.2.1  Carotid Intima Media Thickness and Adventitial Diameter 
Carotid atherosclerosis and atherosclerosis in the coronary and peripheral regions are 
positively correlated 73,78-80. Moreover, carotid IMT is positively associated with several 
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established risk factors of atherosclerosis including age, weight, SBP, insulin, lipids, smoking, 
inflammation 81 and with prevalent and incident CHD75,76,82,83. The positive association between 
the multi-factorial Framingham risk score and carotid IMT also indicates that there is an additive 
effects of traditional CVD risk factors on IMT 84. Because of high correlation of carotid arterial 
disease with disease of other arterial beds, ease to identify and non invasive in nature, it is widely 
accepted measure of subclinical atherosclerosis 77. 
Carotid adventitial diameter, like carotid IMT, is correlated with established risk factors 
of atherosclerosis and, is positively associated with coronary disease and coronary disease 
syndrome85-90. Since change in arterial diameter occurs ‘very early’ in the atherosclerotic 
process, understanding the change may be helpful in predicting CVD events and thus may 
improve current understanding of atherosclerotic process87,91-93.  
Measurement of carotid Intima-media thickness and adventitial diameter are non-
invasive, reliable, readily available and cost effective tools to measure subclinical burden of 
atherosclerosis. The B-mode ultrasound methodology, used in measuring IMT and AD, relies on 
acoustic resistance of various tissues and the resultant localization of signal at tissue boundaries. 
Collagenous and calcified tissues have very high relative acoustic independence (on the basis of 
tissue density) which provides clear delineation of the collagenous tunica adventitia of arteries, 
of collagenous atherosclerotic lesions and of the intima-media boundary. Images of right and left 
common carotid artery (CCA), common carotid bifurcation and the first centimeter of the 
internal carotid artery (ICA) as generated by sound waves are commonly used to measure IMT. 
CCA images are taken at diastole on upstroke of the R-wave while bulb and ICA images are 
taken from T-wave to the upstroke of R-wave. Later, an automated software Artery 
Measurement System (AMS) is used to score (for example, an average of the distance from 
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lumen-intima interface to media-adventitia interface in both walls, for common carotid artery) 
each image (figure 2-5). Use of automated software, improves intra- and inter reader variability, 
significantly reduces measurement time, is user friendly and the use of standard algorithm 
reduces the ‘subjectivity’.   
 
Figure 2-5 Schematic view of carotid artery 
 
 
Tunica adventitia includes external elastic lamina, terminal nerve fibers and connective 
tissue containing fibroblasts and tissue macrophages. Vascular remodeling is more a function of 
plaque dynamics than location. In general, the expansive remodeling occurs first because of 
several reasons including hemorrhage into a plaque. While constrictive remodeling occurs 
because of frequent plaque rupture or healing process or accumulation of collagen 93,94. 
Inflammation of adventitia is an early component of atherosclerotic vascular proliferation 93. 
Also, recently it has been understood that cellular elements infiltrating the tunica media and 
intima in atherosclerosis are derived from adventitial myofibroblasts 95,96. Adventitial diameter is 
calculated by adding lumen diameter to IMT of near and far walls of CCA.  
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2.2.2.2 Arterial Stiffness and Aortic Pulse Wave Velocity   
 
Prior studies have found positive associations between central arterial stiffness, as 
measured by aPWV and, cardiovascular and total mortality 97-100. In a cohort of healthy older 
adults, Sutton-Tyrrell et al found levels of aortic stiffness positively associated with 
cardiovascular mortality 97. A study with (n=265) end-stage renal disease and diabetes subjects 
reported a positive association between aortic stiffening and cardiovascular as well as all-cause 
mortality 98. In a Danish study, aortic PWV was a strong predictor of a composite of 
cardiovascular outcomes (cardiovascular mortality, coronary heart disease and stroke) beyond 
traditional cardiovascular risk factors 100.  
Carotid-femoral pulse wave velocity (cfPWV) is a non-invasive, reproducible, an indirect 
measurement of central arterial stiffness 97,100. Generally, once the pulse wave is generated at 
each contraction of the heart, it travels through out the arterial tree. The wave’s speed depends on 
the functional and structural status of the arterial wall through which it is traveling. Incident 
wave travels away from heart while the reflective wave travels towards heart 101. The slow speed 
of the wave (low PWV) suggests normal artery, while faster speed of the wave (high PWV) 
suggests stiffer arteries.  
During diastole, a normal artery continuously ejects the blood through the arterial tree. 
On the other hand, stiff arteries can not accommodate the volume ejected by the left ventricle 
due to limited arterial elasticity, which in turn leads to increased pulse pressure and isolated 
systolic hypertension 102,103. Arterial stiffness is an important determinant of systolic blood 
pressure, pulse pressure and precedes isolated systolic hypertension and is considered as an 
indicator of vascular aging 104.    
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2. 3 Adiposity and Atherosclerosis 
 
Wealth of evidence suggests that obesity lays foundation for several chronic diseases 
including metabolic syndrome, diabetes, dyslipidemia, hypertension, coronary heart disease, 
stroke and some cancers 10,27,105. Metabolic activity of adipocytes in pathogenesis of adverse 
health outcomes may vary depending on organ or tissue of localization rather than whole body 
fat 106. Abdominal adiposity in particular, has been linked to increased cardiovascular morbidity 
and mortality107.  
Several studies have consistently linked obesity to significantly increased rates of 
mortality; however, there is a substantial variation in the actual number attributed to obesity 
across the studies. For the year 2000, Mokdad et al estimated 414,000 deaths due to obesity in 
US, whereas for the same period Flegal et al estimated only 112,000 deaths attributed to obesity 
108,109. Potential explanation for these variations may be because of different analytical 
approaches. Mokdad et al did not adjust for several variables such as hypertension, dyslipidemia, 
genetics etc while estimating the number of deaths due to obesity, which may have 
overestimated the number of deaths. Since the impact of obesity on health outcomes could be 
mediated through different biological mechanism, it may not be appropriate to attribute 400,000 
deaths to obesity alone before adjusting such factors. Authors later acknowledged that the 
numbers were overestimated 110. Similarly, apparent lower number of deaths in overweight 
category as compared to people in normal BMI range in Flegal et al’s study may have been 
underestimated, because BMI range from 25 to less than 30 is an imprecise biomarker of body 
fat and physical activity 27,111.  
Although, biological mechanism of obesity induced CVD is not fully understood yet, 
obesity is thought to be associated with CVDs through a number of biological mechanisms 
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including hypertension, dyslipidemia, insulin resistance, diabetes, endothelial dysfunction, 
inflammatory response, procoagulant, prothrombotic states etc 48. However, some experts argue 
that obesity may have direct negative relation at least to some degree with CVD, in addition to 
mediation through established risk factors. Recently, two mechanisms, alteration in 
haemodynamics and ectopic fat deposition (in heart, blood vessel, kidney, liver and pancreas 
etc), are being considered as potential direct links between obesity and CVD 112-114. 
Haemodynamic system in obese individuals, needs to work harder to meet a higher metabolic 
demand due to increased body size, there by increasing cardiac output and left ventricular stroke 
work 115,116 116. On the other hand, in animal models, significant increase in deposition of fat pads 
in heart, blood vessel and kidney have been observed 117,118. It has been hypothesized that 
increased ectopic fat in heart may lead to increased ventricular stiffness and myocardial 
lipotoxicity. Higher fat deposition in blood vessel may release higher amount of growth factors 
acting on adjacent vascular smooth muscle cells and may secret pro-atherogenic cytokines, while 
accumulation of fat in kidney may also exert abnormal physical pressure within itself, promoting 
sodium retention, ultimately leading to cardiac dysfunction additively 112,119. 
Recent findings suggest that obesity is also associated with a low-level inflammation 
resulting from chronic activation of the innate immune system and which can lead to insulin 
resistance, impaired glucose tolerance and diabetes 47,120-126.  Adipose tissue releases a variety of 
pro-inflammatory cytokines and chemokines, such as TNF-alpha, interleukin- 6 (IL-6), 
monocyte chemoattractant protein 1 and others 47. When compared to adipose tissue of lean 
subjects, adipose tissue of obese subjects release higher amounts of TNF-alpha, IL-6, 
interleukin-8 (IL-8), transforming growth factor β1 (TGF-β1), C-reactive protein (CRP), soluble 
intercellular adhesion molecule (ICAM), monocyte chemotactic protein-1, and pro-coagulant 
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proteins such as plasminogen activator inhibitor type-1 and factor VII 127-129. Visceral adipose 
tissue secretes higher amount of IL-6 and TNF-alpha. IL-6 stimulates lipolysis and hepatic 
triglyceride secretion ultimately leading to hyper triglyceridemia in vivo 130-132. Another 
cytokine, IL-8 impacts directly on endothelial cells by attracting monocytes and promoting 
vascular smooth cell migration 133,134. In the development of atherosclerosis, migration of 
monocytes is considered an integral part. Circulating monocytes adhere to the endothelial layer 
of vessel wall, migrate into vascular interstitium, and phagocytize oxidized LDL and form foam 
cells loaded with lipid 70. Foam cells then start to accumulate within arterial wall forming early 
lesions called fatty streaks which then develop into advanced atherosclerotic plaques containing 
necrotic lipid cores surrounded by proteoglycan matrix and covered by a fibrous cap that 
thickens the intima. Also, pro-inflammatory factors minimize the beneficial effect of some 
cytokines and effect cellular metabolism. TNF-alpha decreases insulin sensitivity; suppresses 
genes involved in uptake and storage of NEFA and glucose, apoptosis as well as stimulates 
production of IL-1 and IL-6 134. TNF-alpha also exerts the inhibitory effect on adiponectin 135,136.  
On the other hand, VAT has been found to release lower amount of adiponectin than 
subcutaneous fat in both lean and obese subjects 137,138. Adiponectin has anti-diabetic, anti-
atherosclerotic and anti-inflammatory characteristics 41,43. Although, biological mechanism of 
beneficial properties of adiponectin is not fully understood yet, it has been believed to decrease 
circulating levels of free-fatty acids by increasing non-esterified free fatty acids (NEFA) 
oxidation in the skeletal muscle thus decreasing triglycerides in the skeletal muscle and reducing 
hepatic triglyceride deposition with resultant improved insulin sensitivity.  
  Obese individuals have substantially higher amount of fat stored in their adipose tissue, 
partly through the diminished inhibitory effects of insulin on lipolysis, to release free-fatty acid 
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in higher rates than non- obese individuals, even under normal physiological condition. Whether 
higher amount of free-fatty acids flux in peripheral circulation and increased availability of free-
fatty acids to tissues play a role in impairing CVD functions is yet to be known 9. For a module 
depicting potential biological mechanism of obesity on the onset of CVD, see figure 2-6.  
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Figure 2-6 Potential biological link between abdominal adiposity and CVD 
Oxidized LDL bind to scanvanger 
receptors on the surface of 
macrophages, ↑influx of lipoprotein, 
formation of foam-cells & local 
inflammation 
Menopausal transition 
Hyperlipidemia Hyperglycemia Inflammation 
Impair kidney function, ↑ absorption of Na+, 
glycation of protein in wall, Impair endothelial  
Hypertension 
Impair endothelial, Loss of 
NO, Influx of monocytes & 
macrophages 
Induce peripheral vasoconstriction & 
volume retention; ↑ haematocrit & 
fibrinogen level, blood more viscous adding 
pressure load to heart 
 
CVD
Ectopic fat  
⇑ed fat accumulation in abdomen 
  24
Differential roles of visceral and subcutaneous fat depots on CVD or subclinical CVD 
have been evaluated by many studies around the globe. Tyrrell et al found statistically significant 
association (p<0.0001) of abdominal fat with aortic stiffening measured by pulse-wave velocity 
in elderly American 139. In a cross-sectional evaluation from the Amsterdam Growth and Health 
Longitudinal Study, at an early 36 years of age, abdominal and truncal subcutaneous fat were 
independently associated with arterial stiffness. However, the relationship between total 
adiposity and arterial stiffness was mediated by other established risk factors such as 
hyperlipidemia, hypertension etc 3. Among Mexican healthy women, visceral adipose tissue 
significantly explained the variation of fasting glucose (28.4%), triglycerides (16.3%), LDL 
(15.8%), total cholesterol (12.4%) 4. Similarly, another study has found VAT as an independent 
predictor of glucose metabolism among older postmenopausal healthy women 5. Wildman et al 
found that BMI, body weight, waist and hip circumference, waist-to-hip ratio as strong correlates 
(<0.0001 for all) of pulse-wave velocity in younger (20-40 years of age) as well as older (41-70 
years of age) Americans 46. A Japanese cross-sectional study found BMI but not WHR is 
progressively and significantly associated with coronary stenosis among males (median age 59 
years) and females (median age 67 years) who had coronary angiography. The study reported 
that the odds of presence of significant stenosis was highest (OR= 2.5, p for trend= 0.02) for the 
fourth quartile of BMI when compared to the first quartile of BMI 140. 
 
  25
2.4 Specific Aims 
 
Although, the probability of dying from CVD at birth for any American is 47%, the risk 
of the disease is substantially increased for menopausal women and older adults. Atherosclerosis, 
which encompasses two aspects of vascular changes; thickening of arteries due to plaque 
accumulation (atheroma) and hardening of arteries (sclerosis) is a major determinant of CVD 
events. Being non-invasive, reliable and cost-effective, carotid IMT, AD and cfPWV are 
considered very important in assessing the status of atherosclerosis in subclinical stage.  
Obesity, particularly abdominal adiposity has been suggested to be a major contributor of 
atherosclerosis and also has been shown to have a strong positive association with CVD events 
across the globe. In contrast, peripheral adiposity is indicated to have a negative correlation with 
atherosclerosis. Although anthropometric measures are most commonly used markers of 
adiposity in clinical as well as research settings, because of its cost and ease of use, they have 
limited ability to differentiate the contribution of fat and lean mass on disease outcomes. Hence, 
newer technologies DXA and CT that are able to differentiate fat and lean mass have been 
suggested as more precise and accurate in measuring total and regional distribution of fat and 
lean mass and to estimate their contribution to disease outcomes. However, whether the newer 
technologies are superior in explaining variability in S-CVD over anthropometric markers, 
particularly BMI, WC and WHR is not clear yet. Hence, the specific aims of this dissertation are 
as follows; 
I.  To investigate a cross sectional relationship of total and regional fat distribution 
with carotid IMT and AD among women passing trough menopausal transition, 
II.  To compare the variances explained by different measures of total and regional 
adiposity on carotid IMT and AD in the same cohort mentioned above and, 
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III.  To compare the variances explained by different measures of total and regional 
adiposity on cfPWV in the above mentioned cohort. 
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3.1     Abstract 
 
Objective:  
To examine the associations of total and regional body fat distribution with the carotid 
intima media thickness (IMT) and adventitial diameter (AD) among women in the menopausal 
transition. 
Method:  
We measured total and regional fat distribution by dual energy x-ray absorptiometry 
(DXA) and, IMT and AD by B-mode ultrasound in 197 healthy Caucasian (70%) and African 
American (30%) women (mean age 50.1 years) participating in an ancillary study to the Study of 
Women’s Health Across the Nation (SWAN).  
Results:  
After adjusting for age, race, menopausal status, insulin, systolic blood pressure (SBP), 
triglycerides, height, high-density lipoprotein (HDL) and smoking status, proportion of higher 
total fat relative to weight was associated with larger AD (beta for each percent increase in total 
fat 0.011, p= 0.03). Proportion of trunk fat relative to total fat was also positively associated with 
AD (beta for each percent increase in trunk fat= 0.014, p= 0.03). In contrast, proportion of leg fat 
relative to total fat was associated with smaller AD, (beta for each percent increase in leg fat= -
0.013, p= 0.03). Women in late peri or post menopausal status had significantly larger AD 
compared to women in pre or early peri menopausal status after adjusting for trunk fat (p= 0.03). 
Significant associations of total and regional fat distribution with IMT became non-significant 
after adjusting for SBP.  
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Conclusion:  
Adiposity is directly associated with AD and may be indirectly associated with IMT 
through SBP. Also, the accumulation of fat in different anatomical regions may have a 
differential role in subclinical atherosclerosis; greater accumulation of fat in the trunk appears to 
have more negative impact on vascular health than fat in the legs. 
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3.2     Introduction 
 
Anthropometric markers of obesity are positively associated with cardiovascular disease 
(CVD) and with traditional risk factors of CVD including; hypertension (HTN), hyperlipidemia, 
type II diabetes and atherosclerosis 10,30,45,46,109,140-142. Recent studies using more precise markers 
of adiposity, distinguishing fat from fat-free mass, indicate opposing roles of abdominal and 
peripheral adiposity on atherosclerosis or its risk factors 6,8,49,50,105,143. For example, higher 
abdominal adiposity has been found to be more strongly associated with increased clinical or 
subclinical CVD than peripheral (leg and arm) or overall adiposity 33,35,139,144-146. A number of 
studies have suggested that mesenteric, pre-peritoneal and subcutaneous fat are positively 
associated with carotid intima media thickness (IMT), a widely accepted marker of 
atherosclerosis147,148, while others have found lower risks of atherosclerosis with increased 
peripheral fat mass, particularly fat mass in lower extremities 7,8,49,50.  
Although anthropometric measures are inexpensive and easy to obtain, they provide only 
approximate estimates of body composition and have limited ability to measure fat mass 
distribution by anatomical region. Thus they may have limited significance in terms of disease 
outcomes. Dual energy x-ray absorptiometry (DXA) is a more sensitive technology that has the 
ability to differentiate adipose tissues from lean tissues and bones. Because of its ability to 
measure body fat with low radiation and its better applicability in large population studies than 
other instruments (computed tomography, magnetic resonance imaging), DXA is now considered 
the gold standard for measuring total and regional distribution of adipose tissue 26. DXA 
differentiates fat mass in body compartments including legs, arms, head and trunk. Exploring 
relationships of fat in the trunk, legs and arms measured by DXA, with subclinical CVD may 
help to elucidate the impact of fat distribution on subclinical CVD. 
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The prevalence of overweight and obesity among females reaches its peak between the 
ages of 45 and 50 years, the age range when most women experience the menopausal transition 
and decreases after the age of 65 years 11. Recent findings suggest that postmenopausal women 
tend to have a higher percentage of torso fat than pre-menopausal women, probably due to a shift 
in peripheral fat or loss of lean mass 51,52,56-59,62,68,149-152. Similarly, the risk of CVD increases 
substantially among women ten years after menopause. Decline in many female hormones at 
menopause may be responsible, at least partly, for increased risk of numerous negative health 
outcomes including android fat accumulation and CVD153-155. These changes in women’s life 
may not just be the function of aging, as perceived by general population, but indicate some 
important yet unknown role of physiological phenomenon. Little is known about regional fat 
distribution and its role in subclinical CVD among women during the menopausal transition. 
Most of the available information regarding the relationship of total and regional fat distribution 
and subclinical CVD are based on pre- versus post-menopausal status. It is important to evaluate 
fat partition and its impact on subclinical CVD during the menopausal transition.  
Hence, the objective of this paper is to examine associations of body composition; total 
and regional body fat distribution measured by DXA with subclinical measures of atherosclerosis 
measured by IMT and adventitial diameter (AD) in healthy women passing through the 
menopausal transition. 
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3.3     Design and Methods 
3.3.1    Study population 
 
Details of the study design and population have been published previously 156. In brief, 
the study of Women’s Health Across the Nation (SWAN) is a multi-center, multi-ethnic, 
longitudinal epidemiological study studying both the physical and psychosocial changes women 
experience during the menopausal transition. Women were recruited (n= 3,302) at seven study 
sites. Each study site recruited Caucasian and one other ethnic group; African American (Boston, 
MA; Chicago, IL; Detroit, MI; Pittsburgh, PA), Hispanic (Newark, NJ), Japanese (Los Angeles, 
CA) and Chinese (Oakland, CA).  Main eligibility criteria for enrollment were: a.) an intact 
uterus and at least one ovary, b.) at least one menstrual period in previous 3-months, c.) no use of 
reproductive hormones in previous 3-months and d.) 42-52 years of age.   
SWAN- Heart is an ancillary study of SWAN, designed to examine risk factors for sub-
clinical CVD in African American (AA) and Caucasian American (CA) women in menopausal 
transition. Six hundred and eight SWAN participants were enrolled in SWAN-Heart at the 
Pittsburgh and Chicago field centers. SWAN participants were eligible for SWAN-Heart unless 
they: a.) were taking medication for diabetes, hypertension or heart arrhythmias, b.) had a history 
of clinical atherosclerosis (MI, angina, intermittent claudication, cerebral ischemia or 
revascularization), c.) had had a hysterectomy and/or bilateral oophorectomy or d.) were taking 
any female hormones. A single baseline SWAN- Heart study was conducted for each participant 
in conjunction with her core SWAN interview at annual follow-up visits 4, 5, 6 or 7.  
Five SWAN sites including Pittsburgh but not Chicago performed annual DXA scans. 
Therefore, the present study is based on data obtained from Pittsburgh only. Figure 3-1 provides 
details related to which SWAN-Heart participants were included in the present analysis. The 
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Institutional Review Board at the University of Pittsburgh approved the SWAN and SWAN-
Heart studies.  
 
3.3.2 Measurements 
 
3.3.2.1 Body fat measurements 
  
DXA methodology determines bone, fat and lean masses based on energy attenuation 
differences. DXA scans were performed by a trained and certified technician, following standard 
protocol on a Hologic QDR 2000 machine in fan-shaped-array mode. Participants were advised 
not to take any medication or supplements containing calcium for at least 24 hours before the 
scan. Subjects reporting the use of x-ray using contrast or any nuclear medicine for one week 
prior to the scan date and those found positive on pregnancy test were not scanned. Participants 
were asked to remove all removable metal objects from the body. The coefficient of variation of 
measurement was 2.1%. 
 
3.3.2.2 Subclinical atherosclerosis  measurements 
 
For the present study, a duplex scanner, Toshiba SSA-270A was used to measure the 
IMT and AD of carotid artery. AD was measured in the CCA while IMT was measured at 
multiple sites of carotid artery. Images for IMT were taken from near and far walls of the distal 
common carotid artery, CC bifurcation and the first centimeter of the internal carotid artery. 
Digitized images were quantified using Artery Measurement System (AMS) software, developed 
in Sweden. The AD of the common carotid was measured directly as the distance from the 
adventitial-medial interface on the near wall to the medial-adventitial interface on the far wall at 
end-diastole. Reproducibility of measures was evaluated by replicating readings on 20 scans 
from these women. The intra-class correlation was 0.98 for IMT and 0.99 for AD.   
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3.3.2.3 Menopausal status 
 
Women with a menstrual period in the past three months with no change in regularity in 
the past 12 months were categorized as pre-menopausal, while women with some change in 
regularity over the previous 12 months were classified as early perimenopausal. Late 
perimenopausal status was assigned to women with no menstrual period within the past 3-
months, but some menstrual bleeding within the past 12 months and post menopausal status was 
assigned to women who did not have menstrual period within the past 12 months. Women 
reporting the use of birth control pills, estrogen, estrogen injection/ patch, combination estrogen/ 
progestin, or progestin pills in the past year were considered hormone therapy users. Women 
with hysterectomy with or with out removal of one or both ovaries were grouped in surgical 
menopause category. Hormone therapy users and women who had surgical menopause were 
excluded from current analysis. Menopausal status was dichotomized by combining 
premenopausal and early perimenopausal in one group and late peri- and postmenopausal into 
another group, because of the small number of women in premenopausal (n= 20) and late 
perimenopausal (n= 22) categories.    
 
3.3.2.4 Additional measures 
Socio-demographic variables including race, age, education level, smoking status and 
physical activities were collected at the initial SWAN study visit. Smoking status was 
categorized as current smoker, past smoker or never smoker. Participants were asked to wear 
light clothing and take off shoes while measuring height, weight and WC. BMI was calculated as 
the ratio of weight in kilograms to height in meters squared. Two blood pressure readings were 
taken in right arm with the participant seated, following at least 5-minutes of rest. The average of 
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these two measurements was used in the analysis. Weekly calibration of portable scales and 
monthly calibration of study clinic based stationary scales were performed. 
 
 
3.3.3 Statistical methods 
 
Analyses were done using SAS version 9.1, SAS Institute, Inc., North Carolina, USA. 
Normality assumptions for continuous and cell count for categorical data were checked. 
Statistical signifcance was based on a p-value of 0.05. 
For current analysis, we used the DXA whole body scan, performed in conjunction with 
the core SWAN visit corresponding to the participant’s baseline SWAN- Heart exam. 
Descriptive statisitics were described in terms of mean ± standard deviation for continuous 
variables and proportions for categorical variables. Categorical variables were compared using 
Chi-square and continuous variables were compared using Analysis of Variance (ANOVA) or 
Kruskal-Wallis test, across tertiles of trunk fat mass. For regression analysis, IMT was 
normalized using log transformation. 
Unadjusted correlations of IMT and AD with body composition variables were 
calculated. Associations of independent (body compostion) and dependent  (IMT and AD) 
variables were assessed with univariate linear regression. Covariates that were signficantly 
associated (p<0.05) with dependent variables in univariate regression models were grouped by 
similarity of the variables and further tested in regression model to identify the variable with the 
most significant association using stepwise selection. For example, diastolic blood pressure 
(DBP), systolic blood pressure (SBP) and heart rate were grouped in one model, while total 
cholesterol, low density lippoprotein (LDL) and triglycerides were grouped in another model. 
Since high density lippoprotein (HDL) is suggested to play protective role on subclinical CVD, 
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opposite to other lipid markers, HDL was not included in the lipid group. Similarly, glucose and 
insulin were included in another model. The base model was developed retaining variables that 
were most significant in group models; SBP, triglycerides and insulin, and adding age, height, 
menopausal status, race, HDL and smoking status.  
Total leg and arm fat masses were obtained by adding left and right leg fat mass, and left 
and right arm fat mass respectively. Total body fat was calculated by adding trunk, total arm and 
total leg fats, excluding fat in the head. Instead of absolute fat mass, proportion of total and 
regional fat distributions were used in the regression models. Proportion of fat in a specific 
anatomical region was calculated as percentage of total fat mass (e.g., proportion of trunk fat= 
trunk fat mass x 100/ total fat mass), while proportion of total fat was calculcated as percentage 
of total body weight; total fat mass x 100/ weight.  
In final multivariate models, log IMT and AD were modeled separately using proportions 
of trunk, leg, arm, or total fat as independent variable, adjusting for the effect of age, height, 
SBP, smoking status, menopausal status, HDL, insulin and race. Regional proportions of fat were 
adjusted for corresponding proportions of lean mass in addition to above mentioned variables. 
Since anthropometric measures were strongly correlated with DXA adiposity markers; weight, 
BMI and WC were not included in the multivariate model. 
Changes in R2 were compared to identify the best predictor of outcome variables among 
markers of regional adiposity by adding them to the base model. Absolute regional fat masses 
rather than the proportions of fat were used to minimize the colinearity effect, because the 
variance inflation ratio associated with fat masses were substantially lower than those associated 
with proportions of fat (22.0 vs 3.5).     
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3.4    Results 
 
Out of 259 women with written consent to participate in the ancillary study, 21 did not 
complete carotid scans and 10 women participated in carotid scan did not participate in DXA 
scans. An additional 31 women (AA= 6 and CA= 25) were excluded because of surgical 
menopause (n=11), hormone replacement therapy use (n= 19) or missing menopausal status (n= 
1). 
Basic characteristics of the study population by tertiles of trunk fat mass are given in 
Table 3-1. A total of 197 women (30% AA and 70% CA) had complete data for the current 
analysis. Mean age of the participants was 50.1 years. Sixty percent of participants were in pre- 
or early perimenopausals status. Means of CCA AD and IMT were 6.6 mm and 0.70 mm, 
respectively.  
The odds of being in upper tertile of trunk fat was significantly higher for women with 
larger AD, thicker IMT, higher total, arm and leg fat masses.  Similarly, heavier women and 
women with higher BMI, WC, total cholesterol, LDL, triglycerides, DBP, SBP, insulin, glucose 
and C-reactive protein had significantly higher odds of being in the upper tertile of trunk fat mass 
(Table 3-1). A statistically significant odds of being in upper tertile of trunk fat mass was 
observed among women who had lower HDL level. Distribution of smoking status was 
significantly different by tertile of trunk fat (figure 3-2). 
Characteristics of women excluded from current analysis were not significantly different 
from that of women included in the analysis except mean age. Excluded women were found to 
be older than women included in analysis (p= 0.03). 
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3.4.1 IMT 
Univariate correlation analysis: 
In an unadjusted correlation analysis, log of carotid IMT was significantly and positivley 
correlated with proportions of; arm fat, trunk fat and total fat. In contrast, proporiton of leg fat 
was negatively correlated with log of IMT. Similarly, log IMT was positively correlated with 
proportion of leg lean while negatively correlated with proportions of trunk and total lean 
masses. Weight,  BMI and WC were also positively correlated with log IMT (Table 3-2).  
 
Multivariate regression analysis: 
None of the markers of total or regional adiposity were found to be significantly 
associated with log IMT after adjustment for age, height, SBP, insulin, triglyceride, HDL, 
menopausal status, race and smoking status. However, SBP and insulin levels were positively 
and significantly associated with log IMT in all models (Table 3-3). The association between 
trunk fat and log IMT did not remain statistically significant after adjusting for SBP.  
 
3.4.2 CCA AD 
Univariate correlation analysis: 
Proportions of trunk fat and total fat were positively and significantly correlated, whereas 
proportion of leg fat was negatively correlated with AD in unadjusted correlation analyses. Other 
variables that had positive correlation with AD were weight, BMI, WC. Proportions of trunk and 
total lean were negatively but proportion of leg lean was positively correlated with AD. Age and 
AD tended to be positively correlated , however the relationship was marginally significant (p= 
0.07).  
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Multivariate regression analysis: 
Proportion of total fat adjusted for above mentioned covarites were positively associated 
with increased AD, p= 0.03. After adjustment for proportion of trunk lean in addition to the 
above mentioned covariates, proportion of trunk fat was also positively associated with enlarged 
AD, p= 0.03. In contrast, proportion of leg fat (p= 0.03) was negatively associated with AD, after 
adjusting for covariates and proportion of leg lean.  
Also, in all regression models with proportions of total or regional fat, women who were 
classified as current smokers appeared to have significantly (p-value from  0.01 to 0.02) larger 
AD when compared to women who were never smokers. AD of the women in later menopausal 
stage was found significantly larger, in all models than that of women in earlier menopausal 
stage, p-value from 0.03 to 0.04 (Table 3-3).   
To identify the best predictor of AD among regional markers of fat distribution, we 
compared the change in R2 while adding regional fat masses to the base model. Trunk fat mass 
(R2= 0.286) explained the most variance in AD, while leg or arm fat mass did not provide more 
information in the model than trunk fat mass (Table 3-4).    
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3.5     Discussion 
In this study, we investigated the association of total body fat and regional fat on average 
carotid IMT and the diameter of the CCA adventitia among healthy women undergoing 
menopausal transition. We found a higher proportion of total fat relative to body weight and a 
higher proportion of trunk fat relative to total fat were each associated with enlarged adventitial 
diameter of the common carotid artery. In contrast, a higher proportion of leg fat relative to total 
body fat was associated with smaller AD. In our analysis, trunk fat mass explained greater 
variance in CCA AD than arm or leg total fats. However, none of the markers of total or regional 
adiposity were independently associated with IMT after adjusting for age, race, menopausal 
status, height, SBP, insulin level, HDL, triglyceride and smoking status.  
The majority of prior studies evaluating the relationship of body size with vascular health 
have used anthropometric measurements such as BMI 142,155,157, WC 158, WHR 159, abdominal 
diameters 160. Our findings are consistant with their results. Wildman et al found WC and BMI 
positively associated with CCA AD in US young adult population46,  while Jensen-Urstad et al 
reported BMI associated with CCA diameter among Swedish females but not males 87. Both of 
these studies had fewer women than our study. Participants were younger (age range 20-40 
years) in the former study and older (mean age 55 years) in the later study compared to our 
study. More importantly, we examined similar relationships but with more precise measure of 
adiposity using DXA methodology among women in menopausal transition. Another large study 
(n= 1,014) from Germany found positive association of lumen diameter with BMI, WC, fat mass 
(using bio-inpedance methodology) and fat-free mass 158. In present analysis among US women 
only, we used AD diameter (lumen plus intima-media thickness) rather than just lumen diameter. 
In Healthy Women study, Patel et al found weight as an independent major risk factor of 
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increase in aortic diameter among post-menopausal women 161. They used abdominal and iliac 
adventitial diameters, whereas we used CCA AD of women in menopausal transition.   
To our knowledge, present study is the first to report an significant association of total, 
trunk and leg fat depots with AD among women in menopausal transition.  
Relationship of adiposity and subclinical atherosclerosis has been found consistently. In 
particular, abdominal fat accumulation is suggested to increase the risk for CVD mortality and 
morbidity more than any other regional fat depots 26,33,49,144,162. Consistent with this concept, 
current study shows a positive and statistically significant relationship between abdominal 
adiposity and enlargement of CCA AD. Recent studies indicate that enlargement of AD may 
precede IMT thickening and thus it may be a very early stage of atherosclerosis 93,94,96. Also in 
our study, proportion of trunk fat explained more variance in AD than proportions of leg or arm 
fats. This may be because of the capacity of visceral adipose tissue to deliver higher amount of 
free fatty acids by releasing them directly into the circulation system 26,105,163. Also, adiposity is 
associated with release of cytokines which may in turn play important role in the progression of 
atherosclerosis. Abdominal adiposity has been suggested to be inversely correlated with 
adiponectin and positively correlated with inflammatory markers including interleukin- 6 (IL-6), 
tumor-necrotizing factor α (TNF- α) 26,38,105. It has been suggested that IL-6 and TNF-α 
contribute to increased inflammation, while lower adiponectin level may play role in increased 
insulin resistance. Both of these biological proccesses are believed to be independently involved 
in the progression of atherosclerosis 26,38. In addition, a number of other biological mechanisms 
including alteration in renin-angiotensin system 164, or increased leptin levels 165 have been 
observed with increasing abdominal adiposity, which may increase fluid volume by retaining 
sodium, indirectly leading to enlarged AD 166,167 168. 
  42
On the other hand, prior studies have suggested an inverse relationship of peripheral 
adiposity, particularly fat accumulation in the lower extremities, and atherosclerosis 8,50. 
Consistent with this hypothesis, our analysis also revealed that proportion of leg fat relative to 
total fat was negatively and significantly associated with AD. A recent study found negative 
correlation between fat in lower extremities and, glucose and lipid levels (risk factors of 
atherosclerosis) in elderly population 6. A small study with 95 postmenopausal women reported a 
negative association of leg fat with fasting insulin and triglycerides, both risk factors for 
subclinical CVD, even after controlling for trunk fat (accessed by DXA)7. Similarly, other 
studies also found lower levels of atherogenicity with increased peripheral fat mass and leg fat 
percentage 8,49,50. Although, the mechanism involved in the observed negative association of leg 
fat and cardiovascular risk profile is largely unknown, a few hypotheses have been suggested. 
Adipocytes in the leg, particularly in the femoral-gluteal region, are relatively sensitive to anti-
lipolytic activity while being less sensitive to pro-lipolytic activity, limiting the release of free 
fatty acids 169. This increased uptake of free fatty acids in femoral-gluteal region may limit the 
ectopic fat deposition in the blood vessel, thus limiting the release of vasoactive substances 
including inflammatory markers, ultimately helping AD to maintain its structure.  
Measures of total and regional proportion of fat were not associated to IMT after 
adjusting for age, race, menopausal status, height, SBP, insulin, HDL, smoking status and 
triglyceride. Previous studies assessing the association of total body fat or regional fat 
distribution on IMT are inconsistent. Studies that reported an independent positive association of 
total or regional adiposity with IMT have mostly used anthropometric measurements such as 
weight 161, BMI 155, WC 144. In contrast, other studies using more precise markers of regional fat 
distribution such as sagittal or transverse diameters 160, visceral fat area 148, fat mass 3 did not 
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find significant association after adjusting for potential confounders and/or covariates similar to 
our’s. A cross-sectional study which is very close to the present study in terms of outcome and 
predictor measurements, did not find significant realtionship between CCA IMT and fat mass 
after adjusting for lean mass 3. In our study, the association of total and regional proportions of 
fat with IMT lost statistical significance when we added SBP in the model. This may indicate 
that the impact of adiposity on atherosclerosis in this population might be mediated via other 
biological mechanism such as hypertension.   
 The observed positive association of markers of regional fat distribution with AD and 
lack of such association with IMT may be best explained by the theory that AD enlargement 
precedes IMT thickening93. Recent work in animal models suggest that enlargement of AD may 
precede IMT thickening, especially in case of vascular injury in coronary arteries94,170. 
Alternatively, it is possible that the mean value of IMT in our study is below the cut point for 
‘high risk’. Although a widely-accepted exact cut-off value of IMT still needs to be defined, 
experience from prior epidemiological and observational studies indicate that CCA IMT of 1.0 
mm or more is considered high risk group for future CVD events in general population73,75,76,83. 
Since our study population is in ‘very early’ stage of atherosclerosis as indicated by mean CCA 
IMT of 0.70 mm, a signifcant association of adiposity with IMT may not be apparent at this 
point.  
Relatively small sample size, smaller proporitons of women in premenopausal and late 
peri-menopausal status were the main limitations of the present study. Since the present study is 
cross-sectional by design, the results can not be inferred as causal.   
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3.6     Conclusion 
Current study suggests that accumulation of fat in different anatomical regions possess 
direct or indirect differential roles in subclinical atherosclerosis among women in menopausal 
transition. Abdominal fat accumulation may be related to increased IMT through hypertension, 
while it may be directly associated to the enlargement of AD. Overall, fat accumulation has 
negative impact on subclinical atherosclerosis, however retaining higher proportion of fat in the 
lower extremities relative to the total body fat may have favorable impact.   
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Figure 3-1. Flow chart of women included in the analysis. 
453 –SWAN
Pittsburgh 
259 consented to participate 
in SWAN-Heart 
238 with carotid scan 
 
228 with DXA scan
198 without HRT/ Surgical 
menopause 
197- for analysis (59 AA, 138 CA) 
1 missing menopausal status 
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Table 3-1.  Participant characteristics by trunk fat# 
 
Tertile of trunk fat mass (kg) 
Characteristics Combined 
N= 197 
1st tertile 
(2.2 – 10.4)  
N= 65 
2nd tertile 
(10.4 – 16.4) 
N= 66 
3rd tertile 
(17.1 – 37.2) 
N= 66 
P-value 
IMT (mm) 0.70 ± 0.09 0.67 ± 0.07 0.69 ± 0.08 0.72 ± 0.11 0.021 
AD (mm) 6.6 ± 0.6 6.4 ± 0.5 6.7 ± 0.6 6.8 ± 0.6 <0.001 
Arm fat total (kg) 4.5 ± 1.9 2.8 ± 0.7 4.1 ± 0.8 6.5 ± 1.5 <0.001 
Leg fat total (kg) 12.8 ± 4.2 9.4 ± 2.5 12.5 ± 2.8 16.1 ± 3.9 <0.001 
Total fat (kg) 31.8 ± 12.4 19.6 ± 4.5 29.8 ± 4.2 45.9 ± 8.6 <0.001 
African American (%) 30.0 16.9 43.9 28.8 0.169 
Age (years) 50.1 ± 2.6 50.1 ± 2.6 49.8 ± 2.6 50.3 ± 2.5 0.630 
Weight (kg) 76.7 ± 16.9 61.1 ± 7.1 74.1 ± 6.9 94.6 ± 13.9 <0.001 
BMI (kg/m2) 28.9 ± 6.1 23.2 ± 2.1 27.8 ± 2.6 35.6 ± 4.8 <0.001 
Waist (cm) 88.6 ± 14.5 75.0 ± 5.7 86.7 ± 7.1 104.3 ± 10.8 <0.001 
Cholesterol (mg/dl) 197.1 ± 34.1 186.0 ± 28.4 195.6 ± 38.9 209.6 ± 30.4 <0.001 
LDL (mg/dl) 120.5 ± 30.0 110.9 ± 25.4 120.1 ± 33.7 131.4 ± 27.1 <0.001 
HDL (mg/dl) 54.6 ± 12.6 58.5 ± 13.9 56.4 ± 12.1 48.9 ± 9.8 <0.001 
Triglycerides (mg/dl) 105.5 ± 60.1 82.3 ± 28.8 95.4 ± 49.7 141.0 ± 77.3 <0.001 
Glucose (mg/dl) 91.4 ± 14.6 87.4 ± 8.0 90.3 ± 8.7 96.7 ± 21.7 <0.001 
Insulin (uIU/ml) 9.8 ± 6.3 6.9 ± 3.7 9.2 ± 4.9 13.5 ± 7.9 <0.001 
CRP (mg/ l) 3.4 ± 5.1 2.0 ± 3.9 2.6 ± 2.8 5.6 ± 7.6 <0.001 
DBP (mmHg) 72.5 ± 8.6 67.2 ± 7.5 75.0 ± 8.7 75.3 ± 7.3 <0.001 
SBP (mmHg) 114.2 ± 15.2 105.0 ± 10.5 117.3 ± 16.1 120.0 ± 14.0 <0.001 
Menopausal status (%) 
Later  40.1 33.9 48.5 
 
37.9 
 
0.652 
Education (%) 
<High school 
High school 
>High school 
College 
Post graduate 
 
1.0 
21.8 
32.5 
18.9 
25.9 
 
0.0 
21.5 
24.6 
20.0 
33.9 
 
1.5 
24.2 
39.4 
13.6 
21.2 
 
1.5 
19.7 
33.3 
22.7 
22.7 
0.294 
#- Values are expressed as proportions (categorical) and mean ± standard deviation (continuous). 
Later menopausal status = late peri- + post and earlier menopausal status = pre + early peri- 
 P-values are based on ordinal logistic regression. 
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Figure 3-2. Smoking status by tertile of trunk fat 
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Mantel- Haenszel Chi square p= 0.0171
  48
Table 3-2: Correlation of IMT and AD with body composition variables- (Spearman’s) 
 
Subclinical CVD markers (n= 197) 
Predictors Average IMT AD 
 Corr coeff p-value Corr coeff p-value 
Age (yrs) 0.13 0.062 0.13 0.067 
Weight (kg) 0.28 <0.001 0.41 <0.001 
BMI (kg/m2) 0.31  <0.001 0.37 <0.001 
WC (cm) 0.36 <0.001 0.39 <0.001 
Arm fat (%)  0.16 0.026 0.11 0.142 
Leg fat (%) -0.21 0.003 -0.32 <0.001 
Trunk fat (%) 0.19 0.009 0.32 <0.001 
Total fat (%) 0.20 0.005 0.29 <0.001 
Arm lean (%) 0.13 0.061 0.19 0.007 
Leg lean (%) 0.18 0.011 0.25 <0.001 
Trunk lean (%) -0.22 0.002 -0.30 <0.001 
Total lean (%) -0.19 0.007 -0.29 <0.001 
 
*Corr coeff- correlation coefficient.  
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Table 3-3: Association of IMT and AD with total and regional fat proportions 
 
Variables Log IMT AD 
 β (p-value) β (p-value) 
Base Model R2= 0.2248 R2= 0.2251 
Age (yrs) 0.002 (0.58) 0.001 (0.94) 
African American -0.011 (0.60) 0.133 (0.17) 
Later menopausal status 0.021 (0.32) 0.201 (0.04) 
Height (cm) 0.003 (0.65) 0.017 (0.575) 
SBP (per 10 mmHg) 0.024 (<0.001) 0.085 (0.003) 
Insulin (uIU/ml) 0.005 (0.005) 0.012 (0.13) 
HDL (mg/ dl) -0.014 (0.08) -0.026 (0.47) 
Current smokers 0.007 (0.78) 0.258 (0.02) 
Triglyceride -0.002 (0.33) 0.0047 (0.57) 
Model I*-  R2= 0.2248 R2= 0.2450 
Later menopausal status 0.020 (0.32) 0.203 (0.03) 
Total fat (%) 0.00007 (0.95) 0.011 (0.03) 
Model II#-  R2= 0.2259 R2= 0.2622 
Later menopausal status 0.021 (0.31) 0.199 (0.03) 
Trunk fat (%) -0.0007 (0.61) 0.014 (0.03) 
Model III#-  R2= 0.2284 R2= 0.2294 
Later menopausal status 0.020 (0.35) 0.193 (0.04) 
Arm fat (%) 0.004 (0.39) 0.003 (0.89) 
Model IV#-  R2= 0.2253 R2= 0.2551 
Later menopausal status 0.020 (0.33) 0.201 (0.03) 
Leg fat (%) 0.0003 (0.84) -0.013 (0.03) 
 
*- adjusted for age, race, menopausal status, height, SBP, insulin, HDL, triglyceride and smoking status. 
#- adjusted for respective proportions of lean in addition to variables mentioned in a.   
Later menopausal status = late peri- + post- and earlier menopausal status = pre- + early peri-. 
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Table 3-4: Change in R2 on AD by adding regional fat mass* 
 
Variance explained Base model Trunk fat Trunk + leg 
fat 
Trunk + 
arm fat 
Trunk + arm + leg 
fat 
R2 0.224 0.286 0.289 0.287 0.290 
 
*- Absolute fat masses without adjusting lean masses. 
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4.1      Abstract 
Objective  
To compare the variance explained by three methods of adiposity measurement with 
carotid IMT and adventitial diameter among women transitioning through menopause. 
 
Methods  
We investigated 209 healthy Caucasian (69.44%) and African American (30.6%) women 
(mean age 50.3 ± 2.6 years) participating in the Study of Women’s Health Across the Nation- 
Heart (SWAN-Heart) study. Carotid intima media thickness (IMT) and adventitial diameter 
(AD) were measured by B-mode ultrasound. The variability explained by weight, body mass 
index (BMI), waist circumference (WC) and, proportions of total, trunk, leg and arm fat masses 
(measured by dual-energy x-ray absorptiometry (DXA)), and areas of visceral (VAT), 
subcutaneous (SAT) and whole (WAT) adipose tissues (measured by computed tomography 
(CT)) on IMT and AD were compared using multivariate linear regression. 
 
Results  
Multivariate regression model with WC explained slightly more variance in IMT (R2= 
0.252) than the models with VAT, SAT, WAT, proportion of trunk, total, arm and leg fat and, 
BMI, weight and WHR after controlling for age, race, height, menopausal status, LDL, HDL, 
insulin and SBP. Among all measures of adiposity, WC was the only variable positively and 
significantly associated with IMT. Regression models with weight (R2= 0.275), BMI (R2= 0.271) 
and WC (R2= 0.270) explained comparable variance in AD, while models with VAT (R2= 0.258) 
and, proportions of leg (R2= 0.253) and trunk fat (R2= 0.251) both relative to total fat, and 
proportion of total fat (R2= 0.248) relative to weight explained slightly lower variance in AD 
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than by anthropometric measures. Weight (p<0.001), BMI (p=0.001), WC (p<0.001) and, 
proportion of total (p=0.02) and trunk (p=0.03) fat and, VAT (p=0.007) and area of whole 
adipose tissue (p=0.04) were positively associated with AD. In contrast, proportion of leg fat 
(p=0.03) relative to total fat was negatively associated with AD. 
 
Conclusion  
We did not find evidence to support CT or DXA measured measures of adiposity are 
better than anthropometric measures in explaining variances in carotid IMT and AD. WC – 
which is simple, inexpensive, readily available and easy to use - may be better or at least as good 
as VAT or proportion of trunk fat relative to total fat in explaining variability in IMT and AD. 
Abdominal accruement of fat may have more negative impact on S-CVD than added fat in the 
legs. 
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4.2     Background 
 
There is a general consensus in the scientific community that increased adiposity is 
associated with a number of metabolic as well as cardiovascular diseases (CVD)1-6. Reported 
methodologies in available literature to measure adiposity include anthropometric measurements, 
sagittal diameters, dual energy x-ray absorptiometry (DXA), bio-impedance, air displacement 
plethysmography, computed tomography (CT), magnetic resonance imaging. Adiposity, mainly 
assessed by anthropometric measures is positively associated with CVD, subclinical 
cardiovascular disease (S-CVD) as measured by intima-media thickness (IMT) or adventitial 
diameter (AD), and their risk factors7-16. Although anthropometric measures are the most 
commonly used measures of adiposity in clinical as well as research settings due to low cost and 
ease of use, they are unable to differentiate between fat and lean mass. Hence, newer 
technologies DXA and CT that are able to differentiate fat and lean mass have been suggested as 
better ways to estimate the variable effect of fat and lean mass on disease outcomes 17,18. 
However, the superior ability of DXA and CT to explain variability in S-CVD compared to 
anthropometric measures particularly body mass index (BMI), waist circumference (WC) and 
waist to hip ratio (WHR) is not clearly established. Although prior studies indicate fat mass is 
positively and fat free mass is negatively associated with CVD2,3,19-22, there is not enough 
evidence to whether more precise fat measures have stronger associations with CVD or S-CVD 
than traditionally used anthropometric measures of adiposity.  
In a  study by Menke et al., WC had stronger associations than total fat or proportion of 
total fat (measured by bio-impedance method) with several risk factors of atherosclerosis 
including; hypertension, diabetes, decreased HDL, increased triglyceride and increased HOMA- 
insulin resistance6. Another study did not find evidence to support ultra-sonographically 
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measured fat was better than anthropometric measurements in explaining variability in early 
atherosclerosis23. A German study found WC, after adjustment for BMI, to be superior to fat 
mass or percent body fat as measured by bio-impedance, in explaining variability in IMT and 
arterial stiffness24. In another study by Takami et al, intra-abdominal fat area measured with CT 
did not have stronger association with IMT compared to BMI or WC among Japanese males25. 
This clearly warrants further research to identify the best measure of total and regional adiposity 
that explains the most variance in S-CVD. 
 
The Study of Women’s Health Across the Nation (SWAN) and its ancillary study 
SWAN- Heart provide a unique opportunity to explore associations of total and regional 
adiposity measured with CT, DXA and anthropometry with subclinical measures of 
atherosclerosis among Caucasian (CA) and African American (AA) women transitioning through 
menopause. In this study we evaluated associations of total, trunk, arm and leg fat proportions 
(DXA measures); areas of whole adipose tissue (WAT), visceral adipose tissue (VAT) and 
subcutaneous adipose tissue (SAT) (CT measures) and, weight, BMI, WC and WHR 
(anthropometric measures) with subclinical measures of atherosclerosis (carotid IMT and carotid 
AD) among women passing through menopausal transition.  
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4.3     Materials and Methods 
The study of Women’s Health Across the Nation (SWAN) is a multi-center, multi-ethnic, 
longitudinal epidemiologic study investigating the physical and psychosocial changes in middle-
aged women during menopausal transition. Three thousand three hundred and two women were 
recruited at baseline at seven study sites. In addition to Caucasians (CA), each site recruited one 
other ethnic group, African American (AA) (Boston, MA; Chicago, IL; Detroit, MI; Pittsburgh, 
PA), Hispanic (Newark, NJ), Japanese (Los Angeles, CA) and Chinese (Oakland, CA). Main 
eligibility criteria for enrollment were: an intact uterus and at least one ovary, at least one 
menstrual period in previous 3-months, no use of reproductive hormones in previous 3-months 
and 42-52 years of age. Details of the study design and population have been already published 
elsewhere26. 
SWAN-Heart, an ancillary study of SWAN, designed to examine the risk factors 
correlated with sub-clinical CVD in AA and CA women in menopausal transition. Six hundred 
and eight women (participating in SWAN) were enrolled in SWAN-heart from Pittsburgh and 
Chicago. Participants were ineligible if they: a.) were taking medication for diabetes, 
hypertension or heart arrhythmias, b.) had a history of clinical atherosclerosis (MI, angina, 
intermittent claudication, cerebral ischemia or revascularization), c.) had had a hysterectomy 
and/or bilateral oophorectomy or d.) were taking female hormones.  
The first round (baseline) of the ancillary study was conducted in conjunction with core 
SWAN annual interview at visits 4, 5, 6 and 7. Similarly, a follow-up SWAN heart study was 
conducted at SWAN annual follow-up visits 6, 7, 8 or 9. Women who did not participate at the 
baseline but did participate at the follow up of the ancillary study were also included in this 
analysis. Chicago and New Jersey sites did not participate in DXA protocol of SWAN. Since 
Pittsburgh is the only site participated in DXA protocol and had carotid as well as CT scan 
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components of SWAN heart study, the present study is based on the information provided by 
Pittsburgh participants only. The Institutional Review Board at the University of Pittsburgh 
approved the SWAN and SWAN-Heart studies.   
 
4.3.1 Measurements 
 
4.3.1.1 Subclinical atherosclerosis measurements 
 
IMT and AD of CCA were measured on a duplex scanner, Toshiba SSA-270A (Toshiba, 
Shimoishigami, Japan). For IMT, images were taken from near and far walls of the distal 
common carotid artery, CC bifurcation and the first centimeter of the internal carotid artery. The 
AD was measured directly in common carotid as the distance from the adventitial-medial 
interface on near wall to the medial-adventitial interface on far wall at end-diastole. Artery 
Measurement System (AMS) computer software developed in Sweden (Gothenburg, Sweden) 
was used to quantify the digitized images. Reproducibility of measures was evaluated by 
replicating readings on 20 scans from these women. The intra-class correlation was 0.98 for IMT 
and 0.99 for adventitial diameter.   
 
4.3.1.2 Body fat measurements 
  
Weight, height and WC were obtained from SWAN annual visits corresponding to 
SWAN-Heart visits. Measurements were made in light clothing without shoes. Weight was 
measured to the nearest 0.1 kilograms (kg) in standing position and height was recorded to the 
nearest 0.1 centimeter (cm). WC was measured using metric measuring tape to the nearest 0.1 
cm at the narrowest part of trunk (as seen from anterior aspect) above the umbilicus level. For 
WC measurement, participants wore either undergarment only or lightest possible cloth in 
standing position with their abdomen relaxed, arms at sides and feet together. BMI was later 
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calculated by dividing the weight in kg by height meter squared. Weekly calibration of portable 
scales and monthly calibration of study clinic based stationary scales were performed.  
Following standard protocol, a certified technician performed whole body DXA scans on 
a Hologic QDR 2000 machine in fan-shaped-array mode. The Hologic software first categorizes 
each pixel in the scan as bone or soft tissue depending on tissue specific attenuation coefficients. 
Soft tissue is further categorized as fat and fat-free mass again using differential attenuation 
coefficients of fat and fat-free tissues. Participants were advised not to take any medication or 
supplement containing calcium for at least 24 hours before the scan. Participants reporting the 
use of x-ray with contrast such as, barium, IV contrast or any nuclear medicine for one week 
prior to the test date and those who tested positive on pregnancy test were not scanned. 
Participant were advised to remove all removable metal objects including rings, pins in ear or 
head, jewelry from their body. The coefficient of variation of fat measurement was 2.1%. Total 
leg and arm fat masses were obtained by adding left and right leg fat mass, and left and right arm 
fat mass respectively. Total body fat was calculated by adding trunk, total arm and total leg fats, 
excluding fat in the head. Instead of absolute fat mass, proportion of total and regional fat 
distributions were used in the regression models. Regional proportions of fat was calculated as 
percentage of total fat mass (e.g., proportion of trunk fat= trunk fat mass x 100/ total fat mass), 
while proportion of total fat was calculcated as percentage of total body weight (total fat mass x 
100/ weight).  
Images for VAT and WAT were obtained using Imatron C-150 Ultrafast CT scanner 
(Imatron, South San Francisco, CA) following standard protocol. CT produces an array of x-rays 
that pass through the body and are detected by the detectors located on the other side of the 
machine. Cross-sectional images were taken for each slice from different angles and later 
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combined to define each anatomic area. Six-millimeter images between lumbers 4 and 5 were 
digitized and later quantified by using software developed by Accuimage Diagnostic Corporation 
(San Francisco, CA). A region of interest line was drawn at the junction of subcutaneous fat and 
the abdominal wall muscles and was extended to around the body to the back muscles using trace 
function. The area of adipose tissue within the region of interest was determined using a pixel 
range of -190 to -30 Houndsfield Units. The intrabdominal cavity was outlined on the CT image 
and WAT and VAT areas were quantified by trained technician. The difference of WAT and 
VAT was interpreted as area of SAT.    
 
4.3.1.3 Menopausal status  
 
Women with at least one menstrual period in the past 3-months were categorized as 
premenopausal, if they had no change in regularity in the past 12 months and as early peri-
menopausal if they had some change in regularity in the past 12 months. Similarly, women with 
at least one menstrual period in the past 12 months but none in the past 3-months were classified 
as late peri-, while those with no menses in the previous 12 months were categorized as 
postmenopausal. Pre- or early peri- or late peri- menopausal women reporting the use of birth 
control pills, estrogen, progestin or combination estrogen/ progestin in the past year were 
considered hormone therapy users. Women with hysterectomy with or without removal of ovary/ 
ovaries were classified as surgical menopause status. Women in hormone therapy and who had 
surgical menopause were excluded for this analysis. However, postmenopausal women using 
hormone therapy (n= 27) were not excluded from this analysis. Menopausal status was 
dichotomized by combining premenopausal and early peri-menopausal in ‘earlier’ group and, 
late peri- and post- menopausal into ‘later’ group, because the numbers of women in pre- (n= 20) 
and late peri- menopausal (n= 24) were very small.    
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4.3.1.4 Other covariates 
 
Information on race, age, education level, smoking status and physical activities were 
collected at baseline SWAN visit. Women were categorized as current smoker versus past or 
never smoker based on self reported smoking status.  
An average of two blood pressure readings on right arm as participant seated, following 
at least 5-minutes of rest were taken and for at least 30 minutes without smoking or ingesting 
caffeinated beverages. All readings were made to the nearest integer. Insulin, glucose, 
cholesterol, LDL, HDL, triglycerides levels were obtained from a fasting blood sample. All 
blood samples were frozen at -800 Celsius and shipped on dry ice to central laboratory (Medical 
Research Laboratory, Lexington, Kentucky), which is certified by the National Heart Lung and 
Blood Institute, Center for Disease Control 27. Lipids were analyzed on EDTA treated plasma 
while total cholesterol and triglycerides were analyzed by enzymatic methods on Hitachi747 
analyzer 28(Boehringer Mannheim Diagnostics, Indianapolis, IN). Serum insulin was measured 
using solid-phase radioimmunoassay (DPC Coat-A-Count, Los Angeles, CA) procedure, while 
plasma glucose was measured using a hexokinase-coupled reaction (Boehringer Mannheim 
Diagnostics, Indianapolis, IN).  
 
4.3.2     Statistical methods 
 
Normality for continuous variables and cell count for categorical variables were checked. 
Since IMT was not normally distributed, it was transformed into logarithmic scale and log of 
IMT was normal. Descriptive statistics were reported as mean ± SD for continuous variables and 
proportions for categorical variables. Ordinal logistic regression was used to determine the 
increasing or decreasing trend of independent variables and covariates with tertile of IMT. 
Conventional p-value of 0.05 was used to determine statistical significance.  
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Data management and all analyses were done using SAS version 9.1, SAS Institute, Inc., 
North Carolina, USA. Graphs were created using Microsoft Excel 2003 (Microsoft Corporation, 
Redmond, WA, USA).  
 
Associations of dependent and independent variables were first assessed using univariate 
correlations and unadjusted linear regressions. Predictors and covariates significantly associated 
with IMT and AD in univariate regression were grouped by similarity of the variables and 
further tested in linear regression models with stepwise criteria to identify the most significant 
variables. For example, DBP, SBP and heart rate were grouped in one group, while total 
cholesterol, LDL and triglycerides were selected as lipid group. However, HDL was not included 
in the lipid group because it’s biological property is opposite from the rest of the lipid indicators. 
Similarly, glucose and insulin were grouped in another model. Variables found most significant 
in group models; LDL, SBP and insulin, and HDL were then used as a covariates in multivariate 
models.  
To assess the impact of measures of adiposity on S-CVD, we first developed a base 
model including age, race, height and menopausal status only. Then each marker of adiposity 
was added to the base model separately. All measures of adiposity were further tested in fully 
adjusted separate multivariate linear regression models with base variables further adjusting for 
the identified covariates to assess if established risk factors explain more variability in IMT and 
AD. Final multivariate models for both outcome measures were adjusted for the effect of age, 
height, SBP, LDL, HDL, race, menopausal status and insulin level, except the model with BMI. 
Since BMI is a function of height and weight, the effect of height was not adjusted for BMI. In 
addition to above mentioned variables, proportions of trunk, arm and leg fat were further 
adjusted for corresponding proportions of lean mass to minimize the error due to DXA 
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assumption of constant hydration in the lean mass17,29. Multi-collinearity was assessed by 
variance inflation factor (VIF). Any two variables with VIF ≥ 2.0 was considered multi-collinear.    
Prior studies have suggested racial differences in adiposity measurements and 
atherosclerosis. Hence, we also ran race specific fully adjusted regression models for explorative 
purpose only. Since the race specific analyses were lacking statistical power, only primary 
findings of the analyses were reported. 
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4.4     Results  
Two hundred and fifty nine women out of 453 participating in core SWAN study agreed 
in writing to participate in the ancillary study. Of 259 women, 222 completed baseline carotid 
scans as well as CT scans (238 carotid and 222 CT scans), while 184 completed follow-up 
carotid and CT scan (212 carotid and 185 CT scans) for SWAN heart study (fig 4-1). Twenty one 
of 184 women in the follow-up who did not participate in the baseline component were also 
added to the baseline sample yielding total number of women to 243 with carotid and CT scans. 
Out of 243, seven women without DXA scans, 26 on exogenous hormone therapy (n= 15) or 
surgical menopause (n= 11) and one woman scanned in QDR 4500 machine instead of QDR 
2000 were excluded from this analysis. Hence 209 women contribute to the current analysis.  
Baseline characteristics by IMT tertiles are reported in table 4-1. Although 30.6% women 
in our study were AA, 54.3% of women in the highest tertile of IMT were AA (table 4-1). Mean 
values of LDL, insulin, SBP and distolic blood pressure were higher in higher IMT tertiles. 
However, the mean HDL values were lower in higher tertiles of IMT. The proporiton of women 
in later menopausal status (late peri- or postmenopausal) was the highest in the 3rd tertile of IMT.  
Mean values of BMI, area of VAT and, amounts of leg and trunk fat masses for women 
in higher tertiles of IMT were larger than for women in lower tertile of IMT (figure 4-2).  
 
4.4.1 Association with log IMT 
In unadjusted correlation analyses, log IMT was positively correlated with WC, BMI, 
weight, DBP, SBP and areas of VAT, SAT and WAT. Similarly, insulin, proportion of total fat, 
proportion of trunk fat, proportion of arm fat were positively correlated with log IMT. In 
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contrast, SHBG, HDL and proporiton of leg fat were negatively correlated with log IMT (table 
4-2).    
In base regression model containing only age, race, height and menopausal status , 
African American women (p=0.02) were more likely to have thicker IMT (table 4-3a). After 
adding each anthropometric measure of adiposity separately to the base model, the base model 
plus WC explained the most variance (R2=0.230), while the base model plus WHR explained the 
least (R2=0.154) variance in log IMT. Similalry, among DXA adiposity measures, the base 
model plus proportion of leg fat explained the most variance (R2=0.126) while the base model 
plus proportion of arm fat explained the least variance (R2=0.096) in log IMT. Among adiposity 
measures from CT scan plus base model, VAT explained the most variance (R2=0.160) and SAT 
expalined the least variance (R2=0.124) in log IMT. Proportion of total fat was positively 
associated with log IMT (p=0.004), while the proportion of leg fat (p=0.006) was negatively 
associated with log IMT. However, the proportions of trunk (p=0.06) and arm (p=0.07) fats were 
positively associated with log IMT with borderline significance. Areas of VAT (p<0.001), WAT 
(p<0.001) and SAT (p=0.002) were positively associated with log IMT (table 4-3a).  
After adding S-CVD’s established risk factors; SBP, insulin, HDL and LDL to the base 
model, only WC (p=0.03) appeared to be independently associated, while WHR (p=0.05) was 
marginally associated with log IMT. Other measures of adiposity; proportions of total, trunk, arm 
and leg fats, and areas of VAT, SAT and WAT were not independently associated with log IMT 
after adjusting for established risk factors; SBP, insulin, HDL and LDL (table 4-4a).  
When R2 from regression models without established risk factors were compared, the 
model with WC (R2=0.230) explained 96.7% and 30.3% more variances in log IMT than the 
models with proportion of trunk fat (R2=0.117) and area of VAT (R2=0.160), respectively (table 
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4-3a). Also, the model with area of VAT explained 37.1% more variance in log IMT than the 
model with proportion of trunk fat. After adjustment for SBP, insulin, HDL and LDL, the 
difference in variance explained by different measures of adiposity decreased substantially. Even 
after adjustment for established risk factors the model with WC appeared to be as good as the 
models with proportion of trunk fat or area of VAT , explaining 11% and 10% more variances in 
log IMT, respectively (table 4-4a).  
  In race-specific analyses, traditional risk factors explained most of the variance in IMT. 
Although adiposity measures explained very little additional variability in either the AA and CA 
analyses, more variance was explained by the fully adjusted regression model for AA (R2 = 
0.469) than in the fully adjusted regression model for CA (R2 = 0.127). Again, WC appeared to 
be as good as proportion of trunk fat and VAT in explaining variances in IMT for both the races.  
 
4.4.2 Association with AD 
 
AD was positively correlated with weight, WC, BMI, DBP and SBP (table 4-2).  
Similarly, positive correlation of AD with areas of VAT, SAT and WAT, and proportions of total 
and trunk fat were observed. C-RP was also positively correlated with AD. In contrast, 
proportion of leg fat and HDL were negatively correlated with AD. Age (p=0.05) was positively 
correlated with AD while SHBG (p=0.08) was negatively correlated with AD with marginal 
significance.  
In the base model, AA, taller women and women in later menopausal status were more 
likely to have larger AD (table 4-3b). The base model explained 14.6% variance in AD, as 
indicated by R2. When anthropometric measures were added to the base model, weight in 
combination with other base variables explained the most variance (R2=0.272) followed by WC, 
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BMI and WHR plus base variables. However, the differences of variances explained by weight 
and WC in combination with other covariates were minimal. Similarly among other parameters 
of adiposity, the regression model with area of VAT explained the most variance (R2=0.242) 
followed by the models with proportions of total, leg and trunk fats, areas of WAT and SAT, and 
proportion of arm fat (table 4-3b).  
In another phase of analyses, established risk factors of S-CVD; SBP, insulin, HDL and 
LDL were allowed into the minimally adjusted models. Weight, BMI, WC, WHR, proportions of 
total and trunk fats, and areas of VAT and WAT  were found to be positively associated with 
AD, while proportion of leg fat was negatively associated with AD (table 4-4b).   
When R2s from different models without established risk factors were compared, the 
model with WC (R2=0.266) explained 22.1% more variance than the model with proportion of 
trunk fat (R2=0.218) and 8.9% more variance than the model with area of VAT (R2=0.242). Area 
of VAT plus other covariates explained 11.3% more variance than proportion of trunk fat plus 
other other covariates (table 4-3b). After adding established risk factors (table 4-4b), the 
difference on variance explained by models with different measures of abdominal adiposity on 
AD decreased. However, the model with WC still explained more variance than the models with 
proportion of trunk fat by 7.5% and area of VAT by 4.5% in AD,  while the models with area of 
VAT explained 2.7% higher variance than the model with proportion of trunk.   
In a explorative race-specific analyses, the amount of variance explained by the fully 
adjusted regression model for AA (R2= 0.244) was more than the variance explained by the fully 
adjusted regression model for CA (R2= 0.125). The fully adjusted model with proportion of trunk 
fat explained slightly more variance in AD among AA (R2= 0.302) compared to the variances 
explained by the models with WC (R2= 0.262) or VAT (R2= 0.258). However among CA, the 
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fully adjusted model with WC (R2= 0.249) explained slightly more variance in AD than by the 
models with proporiton of trunk fat (R2= 0.165) or VAT (R2= 0.197).  
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4.5     Discussion 
 
In present analysis, anthropometric measures of overall and regional adiposity and more 
precise measures of total and regional fat explained similar variances in log IMT and AD before 
and after adjusting for established risk factors of S-CVD including SBP, insulin, HDL and LDL. 
Our two primary findings are; a.) anthropometic meaures of overall adiposity, weight and BMI 
explained variances comparable to that explained by total body fat measured by proportion of 
total fat relative to weight and, b.) anthropometric measures of abdominal adiposity WC and 
WHR explained varainces comparable to the variances explained by measures of abdominal fat, 
assessed as proportion of trunk fat relative to total fat, VAT, SAT and WAT in log IMT and AD 
of carotid artery. Thus our findings provide no evidence that total or regional measures of fat 
distribution obtained by DXA or CT methodologies are better in explaining variances in 
atherosclerosis despite much higher cost, exposure to radiation and participant’s burden.  
 
This is the first study to our knowledge to compare three methods of adiposity 
measurement in the same study population in terms of S-CVD outcomes among women passing 
through menopausal transition.  
 
Prior studies have compared measures of adiposity obtained by other methodologies such 
as bio-impedance, air displacement plethysmography with anthropometric measures. Our 
findings are consistent with these studies. A study utilizing bio-impedance technology also found 
anthropometric measures as strongly associated as fat measures with a number of disease 
including CVD and diabetes among elderly Britons30. In contrast, in a French study with 1,014 
men and women, slightly older than our subjects, WC, fat mass and percent body fat (assessed 
by bio-impedance analysis) were associated with IMT24. In Czernichow’s study, WC was also 
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associated with pulse wave velocity but not fat mass and percent body fat. A recent cross-
sectional study from Germany did not find superiority of measures of body fatness (measured by 
air-displacement plethysmography) over anthropometric measurements in predicting metabolic 
risk related to obesity31. Furthermore, in a recent meta-analysis (n= 258,114) that evaluated the 
role of WC and WHR on cardiovascular events, de Koning et al confirmed that the risk of CVD 
events increases significantly with increase in WC and WHR1.  
 
Also, in a recent large (n= 12,608) study with US national representative sample Menke 
et al. found WC as a better predictor of risk factors of atheroscelrosis (hypertension, diabetes, 
decreased HDL, increased triglycerides and increased HOMA-IR) than bio-impedance fat 
measures or skinfolds measurements6. Menke et al., compared five measures of adiposity (WC, 
BMI, total body fat and proportion of total body fat), while we compared 11 measures (weight, 
WC, BMI, WHR, proportions of total fat, proportion of trunk fat, proporiton of leg fat, 
proportion of arm fat, VAT, SAT and WAT) of total and regional fat distribution obtained using 
either simple (anthropometric) or sophisticated technology (DXA and CT). Also, they used bio-
impedance technology, whose applicability in real life has been less satisfactory due to 
underlying assumptions of unequal distribution of conductive material in different regions of 
human body and need of populaiton specific equations for analysis 32-35, whereas we used DXA 
and CT.  
A Japanese study on men did not confirm the superiority of intra-abdominal fat (by CT) 
over BMI and WHR in predicting carotid IMT25. Although Takami et al’s study was very close 
to our study in terms of outcome and exposure variables, we used DXA measures in addition to 
CT and anthropometric measures as they have used. In Takami et al’s study, an independent 
association of WC with IMT lost statistical significance after adjusting for BMI, which may be 
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due to collinearity. Our study differed from Takami et al’s study mainly in three aspects; first 
sample selection, they had only male while we analyzed only females; second we adjusted for 
more variables including SBP, insulin, LDL and height which they did not and third, we 
compared DXA adiposity measures in addition to CT and anthropometric measures.      
 
Other studies have reported superiority of WC, WHR over more precisely measured 
abdominal fat indices in predicting S-CVD or its risk factors including insulin resistance, type II 
diabetes, hypertension, dyslipidemia6,23,31,36-38, while other using abdominal fat or VAT have not 
found consistent results25,39-41. Stamatelopoulos et al., reported WC and WHR as stronger 
predictor of early atherosclerosis than ultrasonographically measured fat depots. However, the 
study had fewer subjects who were relatively younger than ours. In a small study (n= 32), Brook 
et al., found WHR as an independent predictor of vascular endothelial dysfunction, a marker of 
early atherosclerosis, indicating abdominal adiposity may play detrimental role on 
atherosclerosis38. In another relatively small (n= 54) study, Goodpaster et al. found subcutaneous 
abdominal fat as an independent correlate of insulin sensitivity even after controlling for visceral 
fat indicating the negative role of overall abdominal fat accruement rather than just VAT in risk 
factor of S-CVD. Area of subcutaneous adipose tissue but not VAT was significantly associated 
with carotid IMT in another small study reported by Lo et al41.   
Abdominal adiposity may influence atherosclerosis indirectly through several biological 
mechanisms including; dyslipidemia, hypertension, hyperglycemia, hyperinsuliminia, releasing a 
number of inflammatory markers3,19,42-44 or directly by imparing endothelial function38,45,46, flow-
mediated dilation23 increasing the availability of free fatty acids47 or some other yet unknown 
mechanisms. Dyslipidemia, hypertension, hyperinsuliminia and inflammatory markers have been 
consistently shown to be an integral part of atherosclerosis42,44. Also, abdominal fat, mainly VAT 
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is thought to be main obesity induced player associated with these risk factors because of it’s 
active pro-lipolytic activity and higher ability to deliver free fatty acids and inflammatory 
markers directly to systemic circulation than other fat depots18. Most importantly, free fatty acids 
released from VAT have direct access to the liver which may impact negatively on hepatic 
insulin activity increasing the risk of atheroscelrosis47. Prior studies have also shown an inverse 
relationship of circulating adiponectin with abdominal adiposity suggesting increased abdominal 
adiposity reduces the amount of circulating adiponectin which is thought to be involved in anti-
atherogenic activity48-51.  
 
Minimal change in R2 after adjusting SBP, insulin, HDL and LDL in AD further suggests 
that certain markers of atherosclerosis (AD in present analysis) may be more sensitive than IMT 
to fat distribution. Majority of the prior studies evaluating the role of VAT on IMT24,41,52 have 
not found positive association while others assessing the role of VAT on other markers of 
atherosclerosis such as pulse-wave velocity4 have reported strong associations. These 
inconsistent findings may suggest that fat may have indirect role on IMT thickenning through 
other biological mechanism mainly SBP and insulin resistance. Our data also support this notion 
as the independent association of proportion of total fat, proportion of trunk fat, VAT, WAT with 
log IMT lost statistical significance after SBP was adjusted.  
 
Main limitation of our study is, our inability to test whether the more variances explained 
by anthropometric measures in log IMT and AD were statistically significant or not as we were 
not aware of any statistical methods comparing R-squares obtained using different variables in 
regression models. Since our study population is women in menopausal transition, we would like 
to caution in applying our findings to male population or women in other stage of life. Race 
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specific analyses were done for an explorative purpose and did not have enough statistical 
power. Also, present study is cross-sectional by design, the findings should not be inferred as 
casual.  
In summary, our data suggests that abdominal adiposity has negative role on S-CVD. In 
present analysis, we found no evidence to support CT or DXA measured adiposity measures are 
better than traditionally used anthropometric measures of adiposity to explain variability in S-
CVD. Measurements of WC require minimal training and is cost-effective. The instruments used 
is a simple non-elastic tape which is inexpenssive, easy to care and easy to carry that does not 
involve any exposure to radiation. Waist circumference a marker of abdominal adiposity may be 
more precise in determining the status of S-CVD than VAT or proportion of trunk fat obtained 
by expensive and highly sophisticated methods such as CT and DXA.  
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259 consented to participate in 
SWAN-Heart out of 453 (SWAN) 
Carotid scan- 238 
CT scan- 222 
Carotid & CT 
scan- 222 
21 in FU but not 
in BL 
222 (BL) + 21 (FU) = 243 
Carotid scan- 212 
CT scan- 185 
Carotid & 
CT scan- 184 
209 for Analysis 
236 matched to DXA 
210 
26 HRT/ Surgical menopause 
1 different DXA machine 
Follow up (FU) Baseline (BL) 
 
  
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1. Flow chart of subject selection. 
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Table 4-1.  Participant characteristics by IMT# 
 
Tertiles of IMT (mm) 
Characteristics Combined 
N= 209 
1st Tertile 
(0.53 – 0.65) 
N= 69 
2nd Tertile 
(0.65 – 0.71) 
N= 70 
3rd Tertile 
(0.72 – 1.18) 
N= 70 
P-value* 
African American (%) 30.6 17.4 28.6 54.3 <0.001 
Age (years) 50.3 ± 2.6 49.6 ± 2.7 50.5 ± 2.5 50.6 ± 2.7 0.030 
AD (mm) 6.6 ± 0.6 6.4 ± 0.5 6.6 ± 0.5 6.9 ± 0.6 <0.001 
Cholesterol (mg/dl) 209.4 ± 39.4 207.4 ± 41.6 208.8 ± 35.4 211.9 ± 41.2 0.487 
LDL (mg/dl) 126.7 ± 35.1 119.6 ± 35.6 128.0 ± 32.8 132.7 ± 36.0 0.034 
HDL (mg/dl) 57.6 ± 14.2 60.5 ± 15.0 58.8 ± 13.8 53.9 ± 13.4 0.009 
Triglycerides (mg/dl) 128.1± 107.5 135.2± 149.9 114.5 ± 73.6 131.5 ± 84.0 0.861 
Glucose (mg/dl) 89.5 ± 19.1 88.8 ± 26.3 87.2 ± 14.9 92.1 ± 13.7 0.233 
Insulin (uIU/ml) 11.4 ± 7.6 9.7 ± 7.0 10.5 ± 6.1 13.6 ± 8.6 0.003 
CRP (mg/ l) 4.0 ± 4.7 4.0 ± 5.2 3.5 ± 4.1 4.5 ± 4.8 0.514 
DBP (mmHg) 72.6 ± 8.7 69.7 ± 8.1 71.0 ± 7.9 77.1 ± 8.4 <0.001  
SBP (mmHg) 114.5 ± 15.7 108.2 ± 12.5 113.0 ± 14.9 122.4 ± 16.3 <0.001 
Menopausal status (%) 
Later 
 
43.1 
 
29.0 
 
47.1 
 
52.9 
 
0.005 
Smoking status (%) 
Yes 
 
14.1 
 
14.5 
 
17.6 
 
10.1 
 
0.486 
Education (%) 
<High school 
High school 
>High school 
College 
Post graduate 
 
0.5 
21.4 
31.6 
18.9 
27.7 
 
1.5 
13.0 
36.2 
18.8 
30.4 
 
0.0 
20.6 
27.9 
26.5 
25.0 
 
0.0 
30.4 
30.4 
11.6 
27.5 
0.142 
#- Values are expressed as proportions (categorical) and mean ± standard deviation (continuous). 
*- P-values are based on unadjusted ordinal logistic regression. 
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Fig. 4-2 Adiposity measures by tertile of IMT* 
 
*- BMI, WC and trunk fat mass were significantly higher with increasing order of IMT tertile (all p-value <0.001). 
Leg fat mass (p= 0.014) and VAT (p= 0.001) were also significantly higher with increasing order of IMT tertile.  
The units are standardized to one standard deviation. The error bars represents ± 1 SD. 
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Table 4-2: Correlation of IMT and AD with predictors- (Spearman’s) 
 
Subclinical CVD Markers 
n= 209 Predictors 
Log of IMT AD 
 Corr coeff p-value Corr coeff p-value 
Age (years) 0.19 0.006 0.14 0.054 
Weight (kg) 0.30 <0.001 0.40 <0.001 
BMI (kg/m2) 0.34 <0.001 0.36 <0.001 
WC (cm) 0.38 <0.001 0.37 <0.001 
Total fat (%) 0.23 0.001 0.32 <0.001 
Trunk fat (%) 0.16 0.018 0.24 <0.001 
Arm fat (%) 0.18 0.009 0.07 0.354 
Leg fat (%) -0.20 0.004 -0.24 <0.001 
VAT (cm2) 0.25 <0.001 0.34 <0.001 
SAT (cm2) 0.23 <0.001 0.28 <0.001 
WAT (cm2) 0.26 <0.001 0.32 <0.001 
Cholesterol (mg/dl) 0.05 0.470 0.03 0.658 
LDL (mg/dl) 0.16 0.030 0.05 0.462 
HDL (mg/dl) -0.22 0.002 -0.15 0.045 
Triglyceride (mg/dl) 0.10 0.184 0.06 0.400 
Insulin (uIU/ml) 0.25 <0.001 0.34 <0.001 
Glucose (mg/dl) 0.18 0.014 0.21 0.004 
C-RP (mg/l) 0.15 0.037 0.27 <0.001 
DBP (mmHg) 0.37 <0.001 0.28 <0.001 
SBP (mmHg) 0.40 <0.001 0.33 <0.001 
Estrogen -0.20 0.004 -0.19 0.008 
SHBG -0.26 <0.001 -0.17 0.018 
DHEAS -0.16 0.020 -0.09 0.202 
FSH 0.13 0.059 0.11 0.125 
IMT- Intima media thickness 
AD- Adventitial diameter.
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Table 4-3a: Base multivariate linear regression models (IMT) 
 
Intima media thickness Variables R2 β (SE) p-value 
Base model 
Age (yrs) 0.007 (0.004) 0.07 
AA vs CA 0.045 (0.019) 0.02 
Height per 10 cm -0.007 (0.014) 0.60 
Later Status vs Earlier 
0.081 
0.029 (0.021) 0.17 
Adiposity & fat measures* 
Weight (kg) 0.194 0.003 (0.0005) <0.001 
BMI (kg/m2)# 0.200 0.007 (0.001) <0.001 
WHR 0.154 0.502 (0.123) <0.001 
Waist (cm) 0.230 0.004 (0.0006) <0.001 
Total fat (%) 0.118 0.003 (0.001) 0.004 
Trunk fat (%) 0.117 0.002 (0.001) 0.06 
Arm fat (%) 0.096 0.009 (0.005) 0.07 
Leg fat (%) 0.126 -0.002 (0.001) 0.03 
VAT (cm2) 0.160 0.0005 (0.0001) <0.001 
SAT (cm2) 0.124 0.0002 (0.00006) 0.002 
Whole fat (cm2)  0.145 0.0002 (0.00004) <0.001 
 
IMT- Intima media thickness 
*- Adjusted for age, race, height and menopausal status. 
#- BMI was not adjusted for height. 
Each adiposity or fat measures were adjusted for all base variables and proportions of trunk fat, arm fat and leg fat 
were also adjusted for respective proportions lean masses.  
β- parameter estimates; SE- standard error of parameter estimates.  
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Table 4-3b: Base multivariate linear regression models (AD) 
 
Adventitial diameter Variables R2 β (SE) p-value 
Base model 
Age (yrs) 0.019 (0.018) 0.29 
AA vs CA 0.318 (0.084) <0.001 
Height per 10 cm 0.162 (0.061) 0.01 
Later Status vs Earlier 
0.146 
0.223 (0.093) 0.02 
Adiposity & fat measures* 
Weight (kg) 0.272 0.013 (0.002) <0.001 
BMI (kg/m2)# 0.235 0.034 (0.006) <0.001 
WHR 0.223 2.65 (0.560) <0.001 
Waist (cm) 0.266 0.015 (0.003) <0.001 
Total fat (%) 0.219 0.020 (0.005) <0.001 
Trunk fat (%) 0.218 0.020 (0.005) <0.001 
Arm fat (%) 0.155 0.030 (0.021) 0.16 
Leg fat (%) 0.218 -0.019 (0.005) <0.001 
VAT (cm2) 0.242 0.003 (0.0006) <0.001 
SAT (cm2) 0.195 0.0009 (0.0002) <0.001 
Whole fat (cm2)  0.219 0.0008 (0.0002) <0.001 
 
AD- Adventitial diameter 
*- Adjusted for age, race, height and menopausal status. 
#- BMI was not adjusted for height. 
Each adiposity or fat measures were adjusted for all base variables and proportions of trunk fat, arm fat and leg fat 
were also adjusted for respective proportions lean masses.  
β- parameter estimates; SE- standard error of parameter estimates 
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Table 4-4a: Multivariate fully adjusted linear regression models (IMT) 
 
Intima media thickness Variables R2 β (SE) p-value 
Base model 
Age (yrs) 0.003 (0.004) 0.37 
AA vs CA 0.015 (0.020) 0.46 
Height per 10 cm -0.007 (0.014) 0.59 
Later Status vs Earlier 0.015 (0.021) 0.47 
LDL per 10 mg/dl 0.004 (0.026) 0.17 
HDL per 5 mg/dl -0.007 (0.003) 0.04 
Insulin uIU/ml 0.002 (0.001) 0.23 
SBP per 10 mmHg 
0.224 
0.024 (0.006) <0.001 
Adiposity & fat measures* 
Weight (kg) 0.230 0.0008 (0.0007) 0.25 
BMI (kg/m2)# 0.230 0.002 (0.002) 0.21 
WHR 0.247 0.286 (0.146) 0.05 
Waist (cm) 0.252 0.002 (0.0008) 0.03 
Total fat (%) 0.224 -0.0002 (0.001) 0.85 
Trunk fat (%) 0.227 -0.001 (0.002) 0.40 
Arm fat (%) 0.229 0.004 (0.005) 0.40 
Leg fat (%) 0.226 0.0009 (0.001) 0.54 
VAT (cm2) 0.227 0.0001 (0.0002) 0.43 
SAT (cm2) 0.224 0.000 (0.00006) 0.99 
Whole fat (cm2)  0.224 0.00001 (0.00005) 0.80 
 
IMT- Intima media thickness 
*- Adjusted for age, race, height, menopausal status, SBP, insulin, HDL and LDL. 
#- BMI not adjusted for height. 
Each adiposity or fat measures were adjusted for all base variables and proportions of trunk fat, arm fat and leg fat 
were also adjusted for respective proportions lean masses.  
β- parameter estimates; SE- standard error of parameter estimates 
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Table 4-4b: Multivariate fully adjusted linear regression models (AD) 
 
Adventitial diameter Variables R2 β (SE) p-value 
Base model 
Age (yrs) 0.007 (0.019) 0.72 
AA vs CA 0.233 (0.098) 0.02 
Height per 10 cm 0.146 (0.065) 0.03 
Later Status vs Earlier 0.232 (0.010) 0.03 
LDL per 10 mg/dl 0.0008 (0.013) 0.95 
HDL per 5 mg/dl -0.008 (0.017) 0.61 
Insulin uIU/ml 0.008 (0.006) 0.21 
SBP per 10 mmHg 
0.224 
0.081 (0.030) 0.008 
Adiposity & fat measures* 
Weight (kg) 0.275 0.011 (0.003) <0.001 
BMI (kg/m2)# 0.243 0.027 (0.009) 0.003 
WHR 0.258 2.364 (0.146) 0.001 
Waist (cm) 0.270 0.014 (0.004) <0.001 
Total fat (%) 0.248 0.014 (0.006) 0.02 
Trunk fat (%) 0.251 0.016 (0.007) 0.03 
Arm fat (%) 0.225 0.014 (0.025) 0.58 
Leg fat (%) 0.253 -0.016 (0.007) 0.02 
VAT (cm2) 0.258 0.002 (0.0008) 0.007 
SAT (cm2) 0.235 0.0005 (0.0003) 0.12 
Whole fat (cm2)  0.244 0.0005 (0.0002) 0.04 
AD- Adventitial diameter. 
*- Adjusted for traditional risk factors; SBP, insulin, HDL and LDL. 
#- BMI not adjusted for height. 
Each adiposity or fat measures were adjusted for all base variables and proportions of trunk fat, arm fat and leg fat 
were also adjusted for respective proportions lean masses.  
β- parameter estimates; SE- standard error of parameter estimates 
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5.1     Abstract 
 
Objective 
 To compare the variances explained by three different methods of total and regional 
adiposity measurements on carotid femoral pulse wave velocity (cfPWV) among women in 
menopausal transition. 
 
Methods 
Carotid femoral pulse wave velocity (cfPWV) was measured in the right common carotid 
and right femoral artery in 209 healthy Caucasian (69.44%) and African American (30.6%) 
women with mean age 50.6 ± 2.6 years, enrolled in the Study of Women’s Health Across the 
Nation- Heart (SWAN-Heart). Multivariate linear regression was used to assess the variances, as 
indicated by R2, explained by regression models with weight, body mass index (BMI), waist 
circumference (WC), waist to hip ratio (WHR); dual-energy x-ray absorptiometry (DXA) 
measured proportions of total, trunk, leg and arm fat mass, and computed tomography measured 
areas of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT) and whole adipose 
tissue (WAT). 
 
Result 
In a separate multivariate regression models, BMI, weight, WC, proportion of total fat as 
measured by DXA and areas of VAT, SAT and WAT as measured by CT were each positively 
associated with log cfPWV even after adjusting for age, race, height and menopausal status . 
After further adjustment for systolic blood pressure, insulin and C-reactive protein, only the 
proportion of total fat relative to the body weight remained positively associated with log 
cfPWV. Models including above mentioned covariates and weight (R2= 0.102), BMI (R2= 
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0.101), WHR (R2= 0.087), WC (R2= 0.095), proportions of total (R2= 0.110) and trunk (R2= 
0.099) fat, areas of VAT (R2= 0.103), SAT (R2= 0.093) and WAT (R2= 0.098) explained 
comparable variance in cfPWV.  
 
Conclusion 
These findings indicate that proportion of total body fat has negative impact on arterial 
stiffness even after accounting for the effects of other potential confounder and risk factors. In 
addition, anthropometric measurements of adiposity explained similar variances to the variances 
explained by more precisely measured fat measures using DXA or CT methodologies in arterial 
stiffness. Our findings encourage the use of anthropometric measures in evaluating the role of 
adiposity on arterial stiffness, because the methodology requires minimal training, is cost-
effective and does not involve any risk to the study subjects. 
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5.2     Introduction 
 
Arterial stiffness is characterized by the loss of arterial elasticity which limits the artery’s 
ability to accommodate the volume ejected by the left ventricle eventually leading to increased 
pulse pressure and isolated systolic hypertension103. Arterial stiffness is an important determinant 
of systolic blood pressure194,195 and, in the presence of hypertension, left ventricular 
hypertrophy.196 For that reason, arterial stiffness is considered a reliable indicator of vascular 
aging. Increased arterial stiffness is a risk factor of cardiovascular and all cause 
mortality97,99,197,198, particularly with the presence of co-morbid conditions such as end-stage 
renal disease99 and hypertension199-201. Prior studies have reported positive associations of aortic 
stiffness with cardiovascular disease97,101,202,203, stroke204 and renal disease205.  
 
Pulse wave velocity (PWV) is a measure of arterial stiffness that can be measured 
centrally (carotid-femoral artery) or peripherally206 (carotid, brachial or femoral arteries). 
Carotid-femoral pulse wave velocity (cfPWV) has been reported as a predictor of composite 
cardiovascular end points (cardiovascular mortality, coronary heart disease and stroke) even after 
adjusting for the effect of cardiovascular disease (CVD) risk factors including age, BMI and 
smoking100. cfPWV is a non-invasive, reproducible and well accepted marker of central arterial 
stiffness100,207 and is considered the ‘gold standard’ measurement of arterial stiffness206. Faster 
cfPWV indicates a stiffer artery and vice versa 101,104. Additionally, hypertension, heart rate, 
glucose levels, triglyceride, smoking have been found to be positively correlated with arterial 
stiffness, measured as cfPWV102,208-210. Furthermore, a wide range of adiposity measures 
including BMI46,209,211, WC102,158, total body fat212, trunk fat 3,213, VAT139 have been reported to 
have positive associations with arterial stiffness.  
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Due to its increased lipolytic activity and inflammatory response, abdominal adiposity, 
particularly VAT, is now identified as having more detrimental effects on clinical and subclinical 
CVD than general adiposity, total body fat or peripheral fat 5,26,143. Hence, it may be plausible to 
hypothesize that more precise measures of abdominal adiposity are better predictors of arterial 
stiffness than anthropometric adiposity measures such as WC. A study by Sutton-Tyrrell et al 
reported a positive association of VAT with increased aortic stiffness as indicated by a higher 
cfPWV 139 in older adults. However, such relationship has not been examined among women 
passing through menopausal transition. Also, there are few reports comparing the role of 
different measures of total and regional adiposity including BMI, total fat, trunk fat, VAT and 
WC on pulse wave velocity.  
 
In the present study, we compared the variances explained by three different methods of 
total and regional adiposity measurement on carotid femoral pulse wave velocity. We included 
the following adiposity measurements; i) total, trunk, arm and leg fat proportions obtained by 
DXA methodology, ii) areas of WAT, VAT and SAT measured by CT methodology and iii) 
weight, BMI, WC and WHR measured by anthropometric measurements.  
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5.3     Methods 
 
5.3.1  Study population 
 
The study of Women’s Health Across the Nation (SWAN) is a multi-center, multi-ethnic, 
longitudinal epidemiological study studying the physical and psychosocial changes in women 
experiencing menopausal transition. Three thousand three hundred two women were recruited at 
seven study sites. Each study site recruited Caucasian (CA) and one other ethnic group; African 
American (AA) (Boston, MA; Chicago, IL; Detroit, MI; Pittsburgh, PA), Hispanic (Newark, NJ), 
Japanese (Los Angeles, CA) and Chinese (Oakland, CA).  Main eligibility criteria for enrollment 
were: a.) an intact uterus and at least one ovary, b.) at least one menstrual period in previous 3-
months, c.) no use of reproductive hormones in previous 3-months and d.) 42-52 years of age. 
Details of the study design and population have been published previously 156. 
 
SWAN- Heart is an ancillary study of SWAN, designed to examine risk factors for sub-
clinical CVD in AA and CA women in menopausal transition. Six hundred eight SWAN 
participants were enrolled in SWAN-Heart at Pittsburgh and Chicago. SWAN participants were 
eligible for SWAN-Heart study unless they: a.) were taking female hormones or medication for 
diabetes, hypertension or heart arrhythmias, b.) had a history of clinical atherosclerosis (MI, 
angina, intermittent claudication, cerebral ischemia or revascularization) or c.) had had a 
hysterectomy and/or bilateral oophorectomy.  
A single baseline SWAN- Heart study was conducted for each participant in conjunction 
with her core SWAN interview at annual follow-up visits 4, 5, 6 or 7. Similarly, a single follow-
up SWAN- Heart study was conducted in conjunction with SWAN annual interview at visits 6, 
7, 8 or 9. Five SWAN sites including Pittsburgh but not Chicago performed annual DXA scans. 
Therefore, present study is based on data obtained from Pittsburgh only. Both SWAN and 
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SWAN-Heart studies were approved by the Institutional Review Board of the University of 
Pittsburgh.  
 
5.3.2 Analytic Sample  
 
Figure 5-1 illustrates the details of SWAN-Heart participants included in the present 
analysis. Two hundred fifty nine women out of 453 participating in the core SWAN study at 
Pittsburgh consented to participate in the SWAN-Heart study. Of 259 women, 222 completed 
baseline cfPWV as well as CT protocols (238 cfPWV and 222 CT scans), while 184 completed 
follow-up cfPWV and CT (212 cfPWV and 185 CT scans) protocols for SWAN heart study. All 
222 with concurrent cfPWV and CT data at baseline plus 21 women with concurrent cfPWV and 
CT data at follow-up were eligible for the current study. Of these 243 women, seven did not have 
DXA scans and 26 were either on exogenous hormone therapy or had undergone surgical 
menopause making them ineligible for this analysis. Of the remaining 210 women, one was 
scanned on QDR 4500 machine while the rest were scanned on QDR 2000 and thus she has been 
excluded from this analysis to minimize the noise in the data due to two different models of 
DXA machine. Hence this analysis is based on the information obtained from 209 women.  
 
5.3.3 Measurements 
 
5.3.3.1 Body fat measurements 
 
Anthropometric measurements and DXA whole body scans were obtained during the 
annual SWAN visits corresponding to the SWAN-Heart visits. Weight, height and WC were 
measured in standing position. Weight was measured to the nearest 0.1 kilograms in light 
clothing. Height was measured on a flat surface and recorded to the nearest 0.1 centimeter (cm). 
WC was measured in undergarments or lightest possible clothing with the abdomen relaxed, 
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arms at sides and feet together. WC was measured using metric measuring tape at the narrowest 
part of torso, as seen from anterior aspect, which is normally above the umbilicus level. WC 
measurements were recorded to the nearest 0.1 cm. BMI was calculated as the ratio of weight in 
kilogram to height in meter squared. Weekly calibration of portable scales and monthly 
calibration of study clinic based stationary scales were performed. 
DXA distinguishes bone, fat and lean masses based on energy attenuation differences. 
Following a standard protocol, whole body DXA scans were performed by a trained and certified 
technician on a Hologic QDR 2000 system in fan-shaped-array mode. Participants were asked 
not to take any medication or supplement containing calcium at least 24 hours before the scan. 
Subjects who used contrast for an x-ray or used any nuclear medicine within one week prior to 
the scan date and those found positive on pregnancy test were not scanned. Participants were 
advised to remove all removable metal objects from the body. The coefficient of variation of 
adiposity measurement was 2.1%. Total leg and arm fat masses were obtained by adding left and 
right leg fat mass, and left and right arm fat mass respectively. Total body fat was calculated by 
adding trunk, total arm and total leg fats, excluding fat in the head. Since there are some 
technical problems associated with measuring fat in the head, we excluded head fat from the total 
body fat measurement. We used proportion of total and regional fat distributions in the 
regression models, instead of absolute fat masses, because the proportion of fat provides a better 
measure of  regional fat distribution than absolute fat mass. Proportion of fat in a specific 
anatomical region was calculated as percentage of total body fat mass (e.g., proportion of trunk 
fat= trunk fat mass x 100/ total body fat mass), while proportion of total fat was calculcated as 
percentage of total body weight (total body fat mass x 100/ total body weight).  
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CT scans were performed at each SWAN-Heart visits using Imatron C-150 Ultrafast CT 
scanner (Imatron, South San Francisco, CA). Arrays of x-rays from the source passed through 
the body and were detected by the detectors located on the other side of the machine. Participants 
were asked to hold their breath during the scan. With 200 milliseconds of exposure time, cross-
sectional images were taken for each 6-milimeter slice between lumbers 4 and 5 from different 
angles and later combined to define an anatomic area. Scan data were saved on optical disc and 
were quantified using software developed by Accuimage Diagnostic Corporation (San Francisco, 
CA) at Preventive Heart Care Center (Pittsburgh, PA). Using trace function a region of interest 
(ROI) was identified at the junction of subcutaneous fat and the abdominal wall muscles and was 
extended around the body to the back muscles. The area of adipose tissue within ROI was 
determined using a pixel range of -190 to -30 Houndsfield Units. A trained and certified 
technician identified the intrabdominal cavity and quantified VAT and WAT. The difference of 
WAT and VAT was considered as SAT.     
 
5.3.3.2 Aortic pulse wave velocity measurements 
Aortic pulse wave velocity was measured from the right common carotid and right 
femoral artery taking simultaneous recordings of the arterial flow waves on unidirectional 
transcutaneous Doppler Flowmeter, model number 810-A (Parks Medical Electronics Inc, Aloha, 
OR). Before cfPWV measurement each participant rested in supine position for 30 minutes. For 
each subject, three separate data collection runs, each obtaining a minimum of 10 pairs of 
simultaneously recorded flow waves were performed. An average of the flow waves was 
obtained and the time from the R wave of the electrocardiogram to the foot of the pressure wave 
was determined while scoring. The distance between the carotid and femoral sampling sites was 
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measured using a standard measuring tape over the body surface and divided by the time 
differential in the arrival of the pressure wave.   
 
5.3.3.3 Menopausal status 
Self reported menstrual history was used to determine the menopausal status of the study 
subjects. Women with at least one menstrual period in the past 3-months with no change in cycle 
regularity in the past 12 months were categorized as premenopausal, while women with some 
change in cycle regularity over the previous 12 months were classified as early perimenopausal. 
Late perimenopausal status was assigned to those with no menstrual period within the past 3-
months, but one in the past 12 months. Postmenopausal status was assigned to women who did 
not have menstrual period within the past 12 months. Women reporting the use of external 
female hormones including birth control pills, estrogen, estrogen injection/ patch, combination 
estrogen/ progestin, or progestin pills in the past year were categorized as hormone therapy users. 
Women with hysterectomy with or without removal of one or both ovaries were grouped in 
surgical menopause category. Women who initiated hormone therapy use before experiencing 12 
months without a menstrual period and women who had surgical menopause were excluded from 
current analysis. Because of the small number of women in premenopausal (n= 20) and late 
perimenopausal (n= 24) categories, menopausal status was dichotomized by combining 
premenopausal and early perimenopausal in one group and late peri- and postmenopausal in 
another.    
5.3.3.4 Other covariates 
Other covariates including race, age, education and smoking status were collected at the 
initial SWAN visit. Smoking status was dichotomized as current smoker versus past smokers or 
never smokers.  
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Following a 5-minute rest, two blood pressure readings were taken in right arm with the 
participants seated. The average of these two measurements was used for these analyses. 
Participants were required not to smoke or drink any caffeinated beverages 30 minutes prior to 
the blood pressure measurements.  
As required by the SWAN protocol, a fasting blood sample was obtained and analyzed 
for insulin, glucose, cholesterol, LDL, HDL, triglycerides. Blood samples were stored at 40 
Celsius until plasma and serum were separated and then frozen at negative 800 Celsius. Frozen 
blood samples were shipped to Medical Research Laboratories (Lexington, Kentucky), a 
certified 178 facility. Hitachi 747 analyzer was used to analyze triglycerides and total cholesterol 
and heparin-2M manganese chloride was used to isolate high density lipoprotein (HDL). Low 
density lipoprotein (LDL) was estimated using Friedewald equation214. Plasma insulin was 
analyzed using solid-phase radioimmunoassay procedure (DPC Coat-A-Count, Lost Angeles, 
CA). Plasma glucose was estimated using hexokinase-coupled reaction (Boehringer Manheim, 
Indianapolis, IN). C-reactive protein (CRP) was measured using the Behring Nephelometer II 
(hs-CRP on BN 100, Dade-Behring, Marburg, Germany).     
 
5.3.4 Statistical methods 
 
Data were managed and analyzed using SAS version 9.1 (SAS Institute, Inc., North 
Carolina, USA). Graphs were created using Microsoft Excel 2003 (Microsoft Corporation, 
Redmond, WA, USA).  
Normality assumptions for continuous variables and cell count for categorical variables 
were checked. Since cfPWV was not normally distributed, it was transformed into logarithmic 
scale and log of cfPWV appeared to be normal. Descriptive statistics for continuous variables 
were illustrated as mean ± standard deviation, while that for categorical variables were expressed 
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as proportions. The increasing or decreasing trend of independent variables and covariates with 
cfPWV tertiles were evaluated using ordinal logistic regression. Conventional p-value of 0.05 
was used to judge statistical significance. 
Potential confounders/ covariates associated with both independent and dependent 
variables of interest were identified from available literatures. Associations of adiposity markers 
and covariates with cfPWV were assessed with unadjusted correlation analysis and univariate 
linear regression. Variables that were either statistically signficant (p<0.05) or marginally 
significant (0.05 ≤ p < 0.10) with cfPWV in univariate regression models were grouped by 
similarity of the variables and further tested in linear regression model using stepwise criteria. 
For example, diastolic blood pressure (DBP), systolic blood pressure (SBP), pulse rate and pulse 
pressure were grouped in one model, while glucose and insulin were included in another model. 
The most significant variables in each group model (SBP and insulin) were retained for the final 
multivaratie modelling. Since CRP was significantly associated with cfPWV in univariate 
regression and we did not have other markers of inflammation, it was considered for inclusion in 
the multivariate model. None of the lipid markers were associated with cfPWV and thus were not 
considered for inclusion in multivariate model.  
Since age, race and menopausal status are non-modifiable risk factors of cfPWV and the 
total and regional fat distribution depends on height, we forced them into the multivariate 
regression model. An attempt was made to assess the true impact of different measures of 
adiposity on cfPWV by first developing a base model including age, race, height and menopausal 
status only. Then each measure of adiposity was added to the base model separately. Each 
measure of adiposity was further tested in expanded separate multivariate linear regression 
models controling for the identified covariates; SBP, insulin and CRP, in addition to above 
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mentioned base model variables. This would let us to assess if established risk factors explain 
additional variance in cfPWV than that explained by base variables plus adiposity markers. Since 
BMI is a function of height and weight, the height was not included in the model with BMI. 
Regional proportions of fat were adjusted for corresponding proportions of lean mass in addition 
to above mentioned variables to minimize the error due to DXA assumption of constant 
hydration in the lean mass18,215. Multi-collinearity was assessed by variance inflation factor 
(VIF). Any two variables with VIF ≥ 2.0 was considered multi-collinear. 
Since existing liturature suggest racial difference in adiposity measurements as well as in 
arterial stiffness, we also ran race specific fully adjusted regression models for explorative 
purpose only. Since the race specific analyses were lacking statistical power, only primary 
findings of the analyses were reported. 
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5.4     Results 
Table 5-1 illustrates characteristics of the study sample by the tertile of cfPWV. Mean 
age of participants was 50.3 years. One in five (20.9%) women in the lowest tertile of cfPWV 
were AA, while almost one-half of the women in the highest tertile were AA. There was a 
tendency of women in a higher tertile of cfPWV to have higher BMI, pulse pressure, CRP, 
insulin, DBP and SBP. In contrast, pulse rate, total cholesterol, LDL, HDL, triglycerides, 
menopausal status and smoking status were not statistically different by tertile of cfPWV. In 
unadjusted ordinal logistic regression, women with higher mean values of BMI (p≤ 0.001), WC 
(p≤ 0.001), absolute values of trunk fat mass (p≤ 0.001) and leg fat mass (p= 0.001), and area of 
VAT (p= 0.005) were more likely to be in a higher tertile of cfPWV (figure 2). 
In univariate Spearman’s correlation analysis (table 5-2), log cfPWV was positively 
correlated with weight, BMI, WC, WHR, proportions of total and trunk fat, and areas of VAT, 
SAT and WAT. Similarly, pulse pressure, DBP, SBP, CRP and insulin were also positively 
correlated with cfPWV. In contrast, HDL and proportion of leg fat were negatively correlated 
with cfPWV. Among hormonal variables, DHEAS was negatively correlated with cfPWV with 
marginal significance. 
In the multivariate base model, AA women were more likely to have higher values of log 
cfPWV compared to CA women after adjusting for age, height and menopausal status (table 5-
3). In separate regression models including the base variables and one adiposity measures at a 
time, BMI (R2= 0.109), weight (R2= 0.107) and WC (R2= 0.095) were all positively associated 
with cfPWV and the models explained comparable variability in log cfPWV. Among DXA 
parameters, only proportion of total fat (R2= 0.103) was positively associated with log cfPWV. 
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Areas of VAT (R2= 0.095), SAT (R2= 0.082) and WAT (R2= 0.092) were positively associated 
with log cfPWV. 
The base model was then expanded by adding SBP, insulin and CRP which were 
identified as risk factors of cfPWV. In this expanded base model, race was the only variable 
positively associated with log cfPWV (table 5-4). Then each measure of total and regional 
adiposity was entered separately into the expanded model. Among measures of adiposity, 
proportion of total fat (p= 0.042) was positively associated with log cfPWV, while BMI (p= 
0.086) and area of VAT (p= 0.090) were marginally associated with cfPWV. Variability on 
cfPWV explained by the expanded models that included weight (R2=0.102), BMI (R2=0.101), 
WC (R2=0.095), proportions of total (R2= 0.110) and trunk fat (R2= 0.099), areas of VAT (R2= 
0.103), SAT (R2= 0.093) and WAT (R2= 0.098) were comparable. Although models including 
proportions of arm fat (R2=0.149) and leg fat (R2=0.143) explained relatively higher variance on 
log cfPWV than other adiposity markers, neither proportion of arm fat nor the proportion of leg 
fat were associated with cfPWV after adjusting age, race, height, menopausal status, SBP, insulin 
and CRP. The higher variances in cfPWV explained by the models that included proportions of 
leg and arm fat were due to the proportions of leg and arm lean masses, which were also 
included in the models. In fact, proportion of leg lean mass (p= 0.003) was positively and 
proportion of arm lean mass (p= 0.001) was negatively associated with cfPWV. 
The expanded base model explained 58.2% more variance in cfPWV than the base model 
without SBP, insulin and CRP (table 5-5). However, for the individual models that included the 
various adiposity measures, in most cases the addition of SBP, insulin and CRP only increased 
the explained variance minimally (<10%); exceptions were the models for WHR, arm fat and 
area of SAT where the variance increased by 42.6%, 63.7% and 13.4% respectively.  
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We also ran the expanded multivariate models excluding women (n=19) with CRP values 
≥10 mg/l, because higher CRP value (≥10 mg/l) may indicate acute infection which may be 
confounding the relationship of adiposity markers and cfPWV. Since the variances (obtained 
after excluding women with CRP ≥ 10mg/l) explained by the models with weight, BMI, WC, 
and area of VAT were similar to that obtained without excluding women with CRP ≥ 10mg/l, we 
included these women in our primary analysis. However, we should note that in secondary 
analysis excluding women with CRP values ≥ 10mg/l, the relationship of weight, BMI, WC, and 
area of VAT with cfPWV did become statistically significant (data not shown).  
In race specific analysis, although fully adjusted regression models explained more 
variances in AA (R2= 0.258) than in CA (R2= 0.014); the variances explained by WC (R2s 0.021 
for CA and 0.282 for AA), proportion of trunk fat (R2s 0.047 for CA and 0.296 for AA) and 
VAT (R2s 0.057 for CA and 0.262 for AA) were comparable within each race. VAT (p= 0.033) 
and proportion of total fat (p= 0.028) were positively associated with cfPWV among CA but not 
among AA (p-values 0.518 for VAT and 0.717 for proportion of total fat). Among traditional 
risk factors, CRP appeared to be important for AA (p= 0.006) but not for CA (p= 0.964).    
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5.5     Discussion 
This study compares the variance explained by 11 different measures of total or regional 
adiposity, measured by three different methods on arterial stiffness among women in menopausal 
transition. In this analysis, cfPWV variability (as indicated by R2) explained by the regression 
models with anthropometric measures (weight, BMI and WC), DXA measures (proportions of 
total fat relative to body weight and proportion of trunk fat relative to total fat) and CT measures 
(areas of VAT, SAT and WAT) were comparable after adjusting for age, race, menopausal 
status, height, SBP, insulin and CRP. Although in expanded model, base variables plus 
proportion of both leg and arm fat relative to total fat explained slightly more variability on 
cfPWV than other expanded models with measures of total and regional adiposity, associations 
were not statistically significant. In fact, the higher variance explained by the models with 
proportions of leg and arm fat was because of the proportions of the respective lean masses. Only 
proportion of the total fat was positively and significantly associated with cfPWV after adjusting 
for above mentioned covariates in the expanded model. 
While our main focus was to compare the variances explained by different measures of 
adiposity in cfPWV, the observed positive and significant relationship between proportion of 
total fat relative to body weight and cfPWV clearly adds to the body of scientific evidence 
showing that increased fat accumulation in the body poses deleterious effect on arterial elasticity. 
Our findings are consistent with prior studies evaluating the role of BMI, weight, WC and 
area of VAT on arterial stiffness. From the Framingham Heart Study, Mitchell et al reported a 
positive association of BMI with abnormal aortic stiffness after controlling for age 209. However, 
they did not examine similar relationship between WC and arterial stiffness. Our study differs 
from Mitchell’s study in the age of participants (mean age 62 yrs in Mitchell et al’s study vs 50.3 
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yrs in our study) and they included both males and females while our sample had only females . 
A study by Sutton-Tyrrell et al reported a strong positive association (p<0.001) of area of VAT 
and cfPWV among older adults (mean age 74 yrs) 139. Similarly, Mackey et al found a significant 
positive association between WC and cfPWV among elderly adults (mean age 78.2 yrs), 
however, in gender specific analysis, a significant association was limited to only females102. Our 
study sample was younger than in both of these studies. We also adjusted for the effect of CRP, 
an indicator of inflammation, which neither of the other studies did. In fact, our analysis suggests 
that the relationship of area of VAT and cfPWV might be mediated through the inflammation 
or/and insulin resistance as indicated by the altered significance level of associations of weight, 
BMI, WC and area of VAT with cfPWV after CRP and insulin were added to the model. 
In a Polish study, the total fat content (measured by bio-impedance) but not BMI was 
positively correlated with arterial stiffness212. The Polish study used stiffness index, an estimate 
of PWV, while we used cfPWV which is considered the ‘gold standard’ measurement of arterial 
stiffness 206. Ferreira et al found trunk fat mass (measured by DXA) associated with cfPWV, 
however, their study differed from ours in several aspects including analytical approach216. Their 
multivariate model may have been overly adjusted with highly correlated peripheral and trunk fat 
together in a single model, although they mentioned the model was not disturbed by multi-
collinearity. Also, Ferreira et al’s study sample were on average 14 yrs younger than ours, had 
both male and female Caucasians, while we had only females representing two (CA and AA) 
ethnic groups. In another study, with participants on average 19 years older than ours, the trunk 
fat mass (measured by DXA) was associated with peripheral (carotid, brachial and femoral 
arteries) but not with central (carotid-femoral) arterial stiffness as measured by carotid-femoral 
transit time rather than cfPWV 213. The HOORN study did not evaluate an association of the total 
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fat mass with arterial stiffness. All three studies, the Polish, the HOORN and Ferreira et al.’s 
used absolute value of trunk fat mass while we used proportion of fat in the trunk. We considered 
presenting association between absolute trunk fat mass and cfPWV, however, we decided the 
proportion of trunk fat relative to the total fat would be a better marker of abdominal fat 
distribution and would allow us to better evaluate the impact of trunk fat distribution on arterial 
stiffening. 
Several mechanisms explaining the patho-physiological relationship between total and 
regional fat distribution and arterial stiffness have been suggested. Abdominal adiposity is 
associated with increased release of inflammatory markers, increased SBP, higher total and LDL 
cholesterol, increased insulin resistance, decreased HDL cholesterol, because of it’s increased 
pro-lipolytic activity and higher ability to deliver free fatty acids and inflammatory markers 
directly to systemic circulation than other fat depots26. Increased adiposity may release higher 
amounts of circulatory pro-inflammatory markers including tumor-necrosis factor α (TNF- α), 
interleukin 6 (IL-6)26,105,217 and elevated levels of inflammatory markers has been indicated to 
increase arterial stiffness218-221 either by their effect on collagen/ elastin ratio or by impairing 
endothelial function222 or via insulin resistance221,223. Similarly, the association of an increased 
aortic stiffness in the presence of impaired glucose metabolism and type-2 diabetes as suggested 
by previous studies224 might indicate the deleterious role of glycemic imbalance on arterial 
stiffening225. Increased insulin level is suggested to contribute to arterial stiffness by promoting 
oxidative stress, endothelial dysfunction and vascular smooth muscle cell growth213,226. Thus, 
adiposity induced insulin resistance and increased availability of inflammatory markers may 
serve, at least partly, as a link between adiposity and arterial stiffness9,227. Our finding is 
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consistent with this concept, as indicated by the altered association of adiposity measures and 
cfPWV after allowing CRP and insulin in the model. 
Additionally, bioavailability of leptin has been found to be positively correlated with 
adiposity and is suggested to reduce arterial distensibility228. In cell culture, leptin has been 
found to stimulate vascular smooth muscle cell proliferation and migration and thus may also 
influence vessel tone and remodeling229. Similarly, other peptides including adiponectin230 and 
resistin231 may explain, at least partly, the possible link between adiposity and vascular structure 
and function213. Since we did not have information on leptin, adiponectin and resistin, we were 
unable to explore their role on cfPWV in our study population. 
Prior studies exploring the role of lipids on PWV have found minimal or inconsistent 
correlations232-236. In our univariate linear regression analysis, total cholesterol, LDL, HDL and 
triglyceride were not associated with cfPWV.  
Given the cross sectional design of our study, we were unable to explore whether the 
observed associations are casual in nature. Since we are unaware of any statistical procedure to 
compare R2 obtained from two or more regression models with different variables, we did not 
test whether the differences observed in R2s using different measures of adiposity were 
statistically significant.  
To conclude, our findings suggest that total amount of body fat has negative effect on 
arterial stiffness even after we account for other risk factors of arterial stiffness. Furthermore, 
anthropometric measures of adiposity appear to be as good as adiposity measures obtained by 
more sophisticated methodologies (CT and DXA) in explaining variances in arterial stiffness. 
Since anthropometric measurements require minimal training, are cost-effective, the instruments 
are easy to carry and maintain, does not involve radiation exposure, our findings support the use 
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of anthropometric in evaluating the role of adiposity on arterial stiffness. Also, the negative 
effect of total or regional body fat content on arterial stiffness may be mediated through a 
number of biological mechanisms associated with adiposity. 
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Figure 5-1. Flow chart of subject selection. 
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Table 5-1.  Participant characteristics by tertile of pulse wave velocity# 
Pulse Wave Velocity (m/s) 
Characteristics Combined 
N= 209 
1st Tertile 
(3.7 – 7.4)  
N= 67 
2nd Tertile 
(7.4 – 9.1) 
N= 68 
3rd Tertile 
(9.1 – 23.1) 
N= 68 
P-value 
African American (%) 30.6 20.9 25.0 47.1 <0.001 
Age (years) 50.3 ± 2.6 49.9 ± 2.7 50.5 ± 2.8 50.4 ± 2.5 0.248 
Cholesterol (mg/dl) 209.4 ± 39.4 212.4 ± 43.5 206.5 ± 39.0 211.2 ± 35.3 0.875 
LDL (mg/dl) 126.7 ± 35.1 128.9 ± 41.9 124.6 ± 31.4 128.3 ± 31.7 0.908 
HDL (mg/dl) 57.6 ± 14.2 59.8 ± 13.8 56.7 ± 13.6 56.8 ± 15.1 0.224 
Triglycerides (mg/dl) 128.1± 107.5 118.6± 64.8 136.3± 152.8 129.2 ± 86.6 0.663 
Glucose (mg/dl) 89.5 ± 19.1 86.8 ± 10.9 88.4 ± 14.8 93.3 ± 28.1 0.091 
Insulin (uIU/ml) 11.4 ± 7.6 9.8 ± 4.8 10.9 ± 7.7 12.8 ± 8.7 0.039 
CRP (mg/ l) 4.0 ± 4.7 3.0 ± 4.1 3.6 ± 4.1 5.4 ± 5.7 0.004 
DBP (mmHg) 72.6 ± 8.7 71.5 ± 7.9 70.9 ± 9.1 75.3 ± 8.7 0.015  
SBP (mmHg) 114.5 ± 15.7 111.1 ± 14.5 112.0 ± 13.9 120.4 ± 17.2 <0.001 
Pulse Rate (beats/ 30 s) 35.2 ± 4.2 35.1 ± 5.0 35.5 ± 3.7 35.0 ± 4.0 0.909 
Pulse Pressure (mmHg) 41.9 ± 10.3 39.5 ± 3.7 41.0 ± 8.4 45.0 ± 11.1 0.001 
Menopausal status (%) 
Later 
 
43.4 
 
47.8 
 
33.8 
 
48.5 
 
0.917 
Yes Smoking (%) 14.4 14.9 13.2 15.2 0.972 
Education (%) 
>High school 
 
77.6 
 
70.2 
 
85.3 
 
77.3 
 
0.288 
#- Values are expressed as proportions (categorical) and mean ± standard deviation (continuous) 
P-values are based on unadjusted ordinal logistic regression. 
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Figure 5-2. Adiposity measures by tertile of cfPWV 
*- BMI, WC and trunk fat mass were significantly higher with increasing order of cfPWV tertile (all p-value 
<0.001). Leg fat (p= 0.001) and area of VAT (p= 0.005) were also significantly higher with increasing order of 
cfPWV tertile. P-values were based on ordinal logistic regression. 
Note: The units are standardized to one standard deviation. 
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Table 5-2: Correlation of log cfPWV with predictors- (Spearman’s) 
 
Log of cfPWV 
Predictors Correlation coefficient p-value 
Age (years) 0.10 0.171 
Weight (kg) 0.28 <0.001 
BMI (kg/m2) 0.28 <0.001 
WC (cm) 0.28 <0.001 
WHR 0.20 0.004 
Total fat (%) 0.28 <0.001 
Trunk fat (%) 0.20 0.004 
Arm fat (%) 0.08 0.272 
Leg fat (%) -0.21 0.002 
VAT (cm2) 0.23 <0.001 
SAT (cm2) 0.24 <0.001 
WAT (cm2) 0.25 <0.001 
Cholesterol (mg/dl) 0.008 0.913 
LDL (mg/dl) 0.07 0.349 
HDL (mg/dl) -0.16 0.029 
Insulin (uIU/ml) 0.19 0.010 
Glucose (mg/dl) 0.09 0.229 
C-RP (mg/l) 0.24 <0.001 
DBP (mmHg) 0.14 0.046 
SBP (mmHg) 0.20 0.004 
Pulse Pressure (mmHg) 0.22 0.002 
Estrogen -0.01 0.930 
SHBG 0.002 0.976 
DHEAS -0.14 0.056 
FSH -0.08 0.260 
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Table 5-3: Base multivariate linear regression models 
 
Carotid femoral pulse wave velocity Variables Model R2 β (SE) p-value 
Base variables 
Age (yrs) 0.010 (0.008) 0.223 
African American 0.130 (0.040) 0.002 
Later menopausal status -0.007 (0.044) 0.883 
Height (cm) 
0.055 
-0.0003 (0.003) 0.917 
Adiposity measures* 
Weight (kg) 0.107 0.004 (0.001) 0.001 
BMI (kg/m2)# 0.109 0.103 (0.003) <0.001 
Waist (cm) 0.095 0.004 (0.001) 0.004 
WHR  0.061 0.287 (0.270) 0.289 
Total fat (%) 0.103 0.007 (0.002) 0.002 
Trunk fat (%)^ 0.091 0.004 (0.003) 0.145 
Arm fat (%)^ 0.091 0.011 (0.010) 0.264 
Leg fat (%)^ 0.131 -0.003 (0.002) 0.275 
VAT (cm2) 0.095 0.0008 (0.0003) 0.004 
SAT (cm2) 0.082 0.0003 (0.0001) 0.018 
Whole fat (cm2)  0.092 0.0003 (0.0001) 0.006 
 
*- Adjusted for age, race, menopausal status and height.  
# BMI- not adjusted for height 
^- In addition to base variables, proportions of trunk fat, arm fat and leg fat were also adjusted for respective 
proportions lean mass. 
β- parameter estimates; SE- standard error of parameter estimates. 
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Table 5-4: Fully adjusted multivariate linear regression models 
 
Carotid femoral pulse wave velocity Variables Model R2 β (SE) p-value 
Base variables 
Age 0.007 (0.009) 0.438 
African American 0.108 (0.047) 0.022 
Later menopausal status - 0.026 (0.048) 0.586 
SBP mmHg 0.001 (0.001) 0.313 
Insulin uIU/ml 0.001 (0.003) 0.667 
Height (cm) 0.002 (0.003) 0.525 
CRP 
0.087 
0.007 (0.004) 0.126 
Adiposity measures* 
Weight (kg) 0.102 0.003 (0.002) 0.101 
BMI (kg/m2)# 0.101 0.008 (0.004) 0.086 
WHR 0.087 0.006 (0.317) 0.986 
Waist (cm) 0.095 0.002 (0.002) 0.240 
Total fat (%) 0.110 0.006 (0.003) 0.042 
Trunk fat (%)^ 0.099 0.003 (0.003) 0.454 
Arm fat (%)^ 0.149 0.013 (0.011) 0.249 
Leg fat (%)^ 0.143 - 0.002 (0.003) 0.580 
VAT (cm2) 0.103 0.0006 (0.0004) 0.090 
SAT (cm2) 0.093 0.0002 (0.0002) 0.299 
Whole fat (cm2) 0.098 0.0002 (0.0001) 0.161 
 
*- Adjusted for age, race, height, menopausal status, SBP, insulin and CRP.  
#- BMI not adjusted for height. 
^- In addition to base variables, proportions of trunk fat, arm fat and leg fat were also adjusted for respective 
proportions lean mass. 
β- parameter estimates; SE- standard error of parameter estimates. 
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Table 5-5: Change in variance before/after adjusting for SBP, insulin and CRP 
 
Base Model# Expanded Model* 
Variables 
Model R2 Model R2 
% Change in R2 
Base model 0.055 0.087 58.2 
Weight (kg) 0.107 0.102 -4.7 
BMI (kg/m2)@ 0.109 0.101 -7.3 
Waist (cm) 0.095 0.095 0.0 
WHR  0.061 0.087 42.6 
Total fat (%) 0.103 0.110 6.8 
Trunk fat (%)^ 0.091 0.099 8.8 
Arm fat (%)^ 0.091 0.149 63.7 
Leg fat (%)^ 0.131 0.0143 9.2 
VAT (cm2) 0.095 0.103 8.4 
SAT (cm2) 0.082 0.093 13.4 
WAT (cm2)  0.092 0.098 6.5 
 
#- Base model adjusted for age, race, height and menopausal status. 
*- Expanded model adjusted for age, race, height, menopausal status, SBP, insulin and CRP.  
@- BMI not adjusted for height. 
^- Regional proportions of fat were adjusted for respective proportions of lean mass in addition to base variables. 
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6.0     Overall Discussion 
 
6.1 Summary of Findings 
 
According to a CDC report published in 1999, the probability at birth of an American 
eventually dying from major CVD is 47% 69. In general, females develop CVD ten to fifteen 
years later in life than males and CVD prevalence is higher among females after menopause 
(figure 2-6)237. Atherosclerosis has been suggested as the major cause of CVD 10,71 and has been 
positively associated with adiposity. Also, a significant change in total and regional adiposity 
with an overall gain in abdominal fat is frequently observed in women around or after 
menopause. However, research exploring the role of regional adiposity on S-CVD has been 
limited.  
Therefore, in this dissertation, we investigated the role of fat partitioning on subclinical 
atherosclerosis, measured by carotid IMT and carotid AD, and arterial stiffness, measured by 
cfPWV. In chapter 3 we evaluated the role of total and regional adiposity on carotid IMT and 
AD among women in menopausal transition. In chapters 4 and 5, we examined the variance 
explained by different measures of adiposity on markers of atherosclerosis and markers of 
arterial stiffening. All three analyses were cross sectional and participants for all analyses were 
selected from a cohort of CA and AA women transitioning through menopause, enrolled in 
SWAN and SWAN-Heart studies.  
Our results are in agreement with prior reports and extend them in several ways. 
 
Available literature suggests that adiposity, mainly measured by anthropometric markers, 
BMI87,142,155,157,159, WC158, WHR159, abdominal diameters160 is positively associated with 
atherosclerosis. Anthropometric measures are considered indirect measures of adiposity as they 
lack the ability to distinguish fat from lean and bone mass. An increasing number of reports 
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suggest the differential role of regional adiposity on cardiovascular health 8,49,50,105,143,147 but none 
have thoroughly evaluated this relationship in women transitioning through menopause.  
Our findings from the first analysis (chapter 3) suggest that adiposity is directly 
associated with AD among women during menopausal transition, which is thought be a critical 
time point in the process of natural aging. The findings further suggest that higher fat accrued in 
the abdominal area may have more detrimental effects on subclinical atherosclerosis than fat 
accrued in the lower extremities. Prior studies found positive association of BMI 155,159, WC 145 
and IMT, however, other studies with more precise measures of fat such as VAT148, fat mass3 did 
not find significant association after controlling the effect of other covariates similar to ours’ 
including age, race SBP, insulin, smoking status. A theory 93,95, already tested in animal models 
96 that AD enlargement precedes IMT thickening may best explain the observed positive 
association of adiposity measures with AD but not with IMT. Alternatively, it is possible that our 
study population is in ‘very early’ stage of IMT thickening as indicated by mean IMT of 0.70 
mm, a significant association of precise adiposity measures with IMT may not be apparent at this 
stage.   
In second and third analyses (chapter 4 and 5), we evaluated the variances explained by 
11 different measures of adiposity on atherosclerosis (measured as IMT and AD) and arterial 
stiffness (measured as cfPWV). We compared three methods namely; anthropometry, DXA and 
CT of measuring human adiposity in vivo.  Prior studies that compared anthropometry against 
bio-impedance 158,172,180 or air displacement plethysmography 181 or CT 177in relation to CVD or 
its risk factors.  
Anthropometric measurements are most commonly used measures of adiposity in both 
clinical and research settings. Recent understandings of adipose tissue indicate that it is the fat 
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that has deleterious effect on disease outcomes rather than overall mass that includes muscle and 
bone mass. Traditionally used anthropometric measurements are now considered imprecise as 
they lack ability to differentiate fat from lean mass. Hence, newer technologies such as DXA and 
CT that are able to differentiate fat and lean mass are considered more precise and accurate in 
measuring total and regional distribution of fat and lean mass and to estimate their contribution 
to disease outcomes 18,26. There is a substantial need for an ‘ideal’ marker of overall and regional 
adiposity would need to; a.) be accurate in measuring adiposity, b.) predict disease risk in general 
population, c.) be applicable and acceptable in large population studies as well as in clinical 
settings and d.) be precise resulting in small measurement error. Clear agreement on ideal marker 
of overall adiposity and regional adiposity is still far from reach. Technically, sophisticated 
newer methodologies have been indicated as the more accurate for analyzing body composition 
in human. However, superior ability of CT or DXA adiposity measures to explain variability in 
diseases over anthropometric measures is not clearly established. This clearly warrants further 
research in the field to identify an ‘ideal’ or ‘close to ideal’ measure of adiposity that can be 
interpreted in terms of disease outcomes.   
In our second analysis, we found WC as good as more precise fat measures (VAT and 
proportion of trunk fat) in explaining variability in IMT and AD. Our findings suggest 
differential role of regional fat distribution; abdominal adiposity posing deleterious impact on 
AD and IMT and fat distribution in the lower extremities having some beneficial impact on both 
measures of outcome.   
Among three studies158,172,180 that compared adiposity measurements assessed by 
anthropometry against measurements of fat assessed by bio-impedance methodology, the largest 
one172 (n= 12,608) found WC as a better predictor of risk factors of atherosclerosis. In the second 
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study180, fat mass index (total fat mass/ squares of height) had a stronger association with CVD 
than WC, p-values for trend 0.03 vs <0.001. Similarly, the third study158 found a stronger 
association of percent body fat (total fat/ weight) with CCA IMT than WC, p-values <0.0001 vs 
<0.05. Our findings are in agreement with the first study only. We used better measures of 
abdominal fat, proportion of trunk fat relative to total body fat, to compare against WC while the 
second study used fat index and the third study used percent fat. Furthermore, our findings may 
be more robust as the applicability of bio-impedance technology have been less satisfactory in 
real life settings due to the need of population specific equations for analysis and underlying 
assumptions of equal distribution of conductive material in different regions of human body 182-
185.   
Similar to our findings, a Japanese study comparing anthropometric measurements of 
adiposity against CT measurements did not find superior correlation of intra-abdominal or 
abdominal subcutaneous fat and carotid IMT when compared to WC or BMI among men 177. Our 
study confirms Takami et. al’s findings with greater confidence as we adjusted for more 
variables in the regression model than they did and validates their findings to American females 
in the menopausal transition. Bosy-Westphal et al. did not find the direct measure of adiposity 
assessed by air displacement plethysmgraphy methodology better than BMI or WC in explaining 
variances in several indicators of metabolic risk among individuals with high risk of metabolic 
syndromes 181. We confirm their findings in apparently healthy women in menopausal transition 
with two direct methods (CT and DXA) of adiposity.       
Our third analysis (chapter 5) examined the variability explained by eleven different 
measures of total or regional adiposity on arterial stiffness. Direct measures of overall or regional 
adiposity did not explain more variance on arterial stiffness than anthropometric measures after 
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accounting for potential confounders or known risk factors of arterial stiffness. More 
importantly, in our analysis total body fat relative to total weight appeared to impact arterial 
stiffness negatively even after controlling for the effects of potential confounders and risk factors 
of arterial stiffness. 
Prior studies have indicated that direct measures of adiposity might be better predictors of 
arterial stiffness than anthropometric measures 212,213,216. Those studies used absolute values of 
either total or regional fat masses in contrast to the proportion of total and regional adiposity as 
we have used. In fact, we considered examining association between total or regional absolute fat 
masses and cfPWV, however, we decided the proportions of total fat relative to weight and 
proportions of trunk, arm and leg fat relative to total fat mass would be better measures of total 
and regional fat distribution. Our findings are in agreement with the concept that direct measures 
of adiposity might be better predictor of arterial stiffness than anthropometric measures as 
indicated by a positive association of proportion of total fat and cfPWV even after controlling for 
potential confounders/ covariates such as age, race, menopausal status, insulin, height and CRP.  
In conclusion, our first and second analysis suggest that accruement of abdominal fat 
plays negative role in atherosclerosis than fat deposited in other body parts such as fat in the legs. 
The third analysis suggests that the direct measure of total adiposity may play more detrimental 
role in arterial stiffness than direct regional or indirect total or regional adiposity. 
Furthermore, we found WC as good as direct measures of adiposity (VAT or proportion 
of trunk fat) obtained by using newer technologies such as CT or DXA with capabilities to 
distinguish fat from lean tissue in explaining variance in IMT or AD or cfPWV. WC, a measure 
of abdominal adiposity, requiring minimal training, being cost-effective and posing no risk of 
radiation exposure, may be more prominent in determining the effect of adiposity on vascular 
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health than VAT or proportion of trunk fat obtained by expensive and sophisticated technologies 
such as CT or DXA respectively. 
Taken together, the findings from these three analyses support to the concept of 
differential role of excess adipose tissues accumulated in different anatomical regions on 
vascular health. Higher abdominal adiposity appeared to play more detrimental role on 
atherosclerosis than peripheral adiposity, while proportion of total body fat relative to body 
weight appeared to have deleterious effect on arterial stiffness. More importantly, our findings 
indicate that anthropometric measures are as good as sophisticated newer methods that have 
ability to differentiate fat from lean and bone tissues in explaining variances in vascular health.  
 
6.2     Limitations 
 
The SWAN and SWAN-Heart studies provided the unique opportunity to investigate the 
relationship of total and regional adiposity on S-CVD among women in menopausal transition. 
However, there are some limitations applicable to all three papers that should be considered 
when interpreting the findings from this dissertation. 
The study cohort for all three papers consisted CA and AA women in the menopausal 
transition. Thus, the findings from this dissertation may not be generalizable to women from 
other ethnic groups and/ or women in other menopausal status. Although, prior literature has 
indicated that S-CVD and the body fat distribution may vary by ethnic groups, we were unable to 
test if our findings were different for CA and AA because of lack of statistical power. 
More importantly, SWAN is a study of women going through menopause and therefore 
only included women. Hence three analyses in this dissertation were limited to women and the 
findings may not be generalizable to men. 
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Since all three papers were designed as cross-sectional, the association of fat distribution 
and vascular health may not be interpreted as casual. Comparisons of variances explained by 
different measures of adiposity on IMT, AD and cfPWV were solely visual as we are not aware 
of any statistical method that allows to compare different R2 obtained from different linear 
regression models with different variables. Hence, we were unable to test if the observed 
differences in variances were statistically meaningful or not. The altered association of adiposity 
measures and measures of S-CVD after adjusting for traditional risk factors might be due to 
relatively small sample sizes or due to other biological mechanisms involved in between 
adiposity and S-CVD. Also, our ability of detect a significant association of some of the 
adiposity measures and IMT might have been limited because the study population is relatively 
healthy and thus the associations are not apparent at this stage. Since our analyses involved a 
number of multiple comparisons, it may have increased type I errors slightly.   
 
6.3      Public Health Significance 
Obesity and CVD are major public health problems. Two in three Americans are either 
overweight or obese. Although our understanding of CVD and obesity has been improved 
substantially in recent past, CVD still remains the major killer of Americans while obesity is 
increasing in prevalence. In 2003-2004, 32.2% US adults (20 years of age or older) were obese 2. 
Recent findings suggest that obesity has been increasing more rapidly than overweight. 
Proportion of overweight American, aged 20-74 years has increased by more than 45% in 1999-
2002 compared to 1960-1962, while for the same period and age group, obesity rate increased by 
more than 133% 11. Apart from its negative health outcomes, obesity also induces enormous 
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amount of health care expenditure. In 1998 direct cost attributed to obesity (not overweight) was 
70 billions US dollars in the US which was 7% of the US health care expenditure for the year 15.  
In the US, one of the major goal of healthy people 2010 is to substantially increase life 
expectancy in the next 10 years 238 which is likely to translate into bigger burden of chronic 
disease including CVD and obesity as well as economic burden to the state. The continual 
increase in obesity induced disease burden call for better and more aggressive preventive 
strategies on the public health level. Prevention of disease, death and disabilities related to CVD 
and obesity requires early recognition and diagnosis in order for appropriate clinical, lifestyle or 
behavioral intervention. In general, it is understood that increased adiposity increases the risk of 
CVD through a number of indirect pathways. However, the direct relationship of increased 
adiposity and CVD has yet to be established. Elucidating the inter-relationship of regional 
adiposity and CVD may help to understand the mechanistic pathways amenable to lifestyle, 
behavioral and pharmacological intervention in order to delay or prevent future CVD events, 
particularly for people with prevalent obesity. Hence, understanding the biological mechanisms 
of obesity and CVD is of a crucial importance.  
Furthermore, findings from chapters 4 and 5, waist circumference being as good as VAT 
or proportion of trunk fat in explaining variance in IMT, AD and cfPWV are particularly 
important for designing similar future studies. Using waist circumference over other adiposity 
measures obtained from expensive and sophisticated technologies will be cost-effective, poses no 
radiation risk to the subject, needs minimal trainings and is easily replicable. Also, using WC as 
a screening tool to identify people at increased risk for CVD in subclinical level might be an 
advantage in population level to call for an appropriate intervention for primary, secondary or 
tertiary prevention of negative health outcomes. 
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 6.4     Future Research 
Both obesity and CVD are the result of several factors including genetic, environmental 
and behavioral. While many independent studies have indicated a number of biological link 
between obesity and CVD, the agreement on ‘ideal’ or close to ideal measure of total and 
regional body fat distribution is still an elusive goal. It is therefore important to carry out 
epidemiologic longitudinal studies that may lead to the general agreement on the best measure of 
fat distribution. Also, longitudinal investigation of change in regional fat distribution might help 
us to understand the fat re-partition associated with natural aging and its relative importance in 
terms of disease outcomes. Such studies need to be carried out in populations with diverse ethnic 
background, wide age range incorporating both genders. Since longitudinal epidemiological 
studies of fat distribution might be very expensive and burdensome to the study subjects, 
embedding such studies into the studies with other primary outcomes may serve as a better 
option.     
Investigating if WC is as good as VAT or proportion of trunk fat, in other populations, 
particularly in multi-ethnic populations, might be helpful in identifying the best abdominal 
adiposity measure. Also, future studies should be directed to test these findings among men and 
in population with different age groups. Furthermore, if such future studies can confirm our 
results, WC being as good as VAT or proportion of trunk fat in explaining variances in vascular 
health, in other populations that may help to maximize the health care resources as DXA and CT 
methodologies are very expensive as compared to anthropometric method. Additionally, our 
findings call for longitudinal studies in future to test if AD enlargement precedes IMT 
thickening, to identify practical cut-off value for IMT that has clinical significance in population 
level. Identifying clinically significant cut-off values of IMT, one of the most widely used 
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marker of atherosclerosis, might serve as an important tool for secondary or tertiary prevention 
of atherosclerosis.  
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